WO2004043531A2 - Vaccum device for treating tissus adjacent a body cavity - Google Patents

Vaccum device for treating tissus adjacent a body cavity Download PDF

Info

Publication number
WO2004043531A2
WO2004043531A2 PCT/US2003/033775 US0333775W WO2004043531A2 WO 2004043531 A2 WO2004043531 A2 WO 2004043531A2 US 0333775 W US0333775 W US 0333775W WO 2004043531 A2 WO2004043531 A2 WO 2004043531A2
Authority
WO
WIPO (PCT)
Prior art keywords
body cavity
treatment
assembly
tissue adjacent
balloon
Prior art date
Application number
PCT/US2003/033775
Other languages
French (fr)
Other versions
WO2004043531A3 (en
Inventor
Paul Lubock
Original Assignee
Senorx, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senorx, Inc. filed Critical Senorx, Inc.
Priority to JP2004551571A priority Critical patent/JP4563180B2/en
Priority to EP03774946A priority patent/EP1558324B1/en
Priority to DK03774946.2T priority patent/DK1558324T3/en
Priority to AT03774946T priority patent/ATE511874T1/en
Priority to AU2003283014A priority patent/AU2003283014A1/en
Priority to CA2504965A priority patent/CA2504965C/en
Publication of WO2004043531A2 publication Critical patent/WO2004043531A2/en
Publication of WO2004043531A3 publication Critical patent/WO2004043531A3/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/10X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
    • A61N5/1001X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy using radiation sources introduced into or applied onto the body; brachytherapy
    • A61N5/1014Intracavitary radiation therapy
    • A61N5/1015Treatment of resected cavities created by surgery, e.g. lumpectomy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/22Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
    • A61B2017/22038Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for with a guide wire
    • A61B2017/22047Means for immobilising the guide wire in the patient
    • A61B2017/22048Balloons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/22Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
    • A61B2017/22051Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for with an inflatable part, e.g. balloon, for positioning, blocking, or immobilisation

Definitions

  • This invention relates generally to the fields of medical treatment devices and methods.
  • the invention relates to devices and methods for treating tissue surrounding a body cavity, such as a site from which cancerous, pre- cancerous, or other tissue has been removed.
  • a biopsy In diagnosing and treating certain medical conditions, it is often desirable to perform a biopsy, in which a specimen or sample of tissue is removed for pathological examination, tests and analysis.
  • a biopsy typically results in a biopsy cavity occupying the space formerly occupied by the tissue that was removed.
  • obtaining a tissue sample by biopsy and the subsequent examination are typically employed in the diagnosis of cancers and other malignant tumors, or to confirm that a suspected lesion or tumor is not malignant.
  • Treatment of cancers identified by biopsy may include subsequent removal of tissue surrounding the biopsy site, leaving an enlarged cavity in the patient's body.
  • Cancerous tissue is often treated by application of radiation, by chemotherapy, or by thermal treatment (e.g., local heating, cryogenic therapy, and other treatments to heat, cool, or freeze tissue).
  • Cancer treatment may be directed to a natural cavity, or to a cavity in a patient's body from which tissue has been removed, typically following removal of cancerous tissue during a biopsy or surgical procedure.
  • U.S. Patent 5,429,582 to Williams U.S. Patent 5,913,813 to Williams et al.
  • U.S. Patent 5,931 ,774 to Williams et al. U.S. Patent 6,022,308 to Williams
  • U.S. Patent 6,083,148 to Williams and U.S.
  • Patent 6,413,204 to Winkler et al. describe devices for implantation into a cavity resulting from the removal of cancerous tissue which can be used to deliver cancer treatments to surrounding tissue.
  • One form of radiation treatment used to treat cancer near a body cavity remaining following removal of tissue is "brachytherapy" in which a source of radiation is placed near to the site to be treated.
  • Williams and coworkers describe implantable devices for treating tissue surrounding a cavity left by surgical removal of cancerous or other tissue that includes an inflatable balloon constructed for placement in the cavity. Such devices may be used to apply one or more of radiation therapy, chemotherapy, and thermal therapy to the tissue surrounding the cavity from which the tissue was removed.
  • the balloon may be filled with a treatment fluid delivered via a conduit from a receptacle, syringe, or other means, or may receive a solid radiation source placed within the balloon.
  • radiation treatment may be applied to tissue adjacent the balloon by placing radioactive material such as radioactive "seeds" within the balloon, or by filling the balloon with a liquid or slurry containing radioactive material. Multiple treatments may be applied simultaneously.
  • radioactive seeds may be placed within the balloon effective to irradiate tissue surrounding the balloon, and the balloon filled with a hot fluid at the same time to provide thermal treatment. After a suitable time, the hot fluid and/or the radioactive seeds may be removed. Such treatments, combined or otherwise, may be repeated if desired.
  • a "MammoSite ® Radiation Therapy System" For example, a "MammoSite ® Radiation Therapy System"
  • the radiation source includes a balloon catheter with a radiation source that can be placed within a tumor resection cavity in a breast after a lumpectomy. It can deliver a prescribed dose of radiation from inside the tumor resection cavity to the tissue surrounding the original tumor.
  • the radiation source is typically a solid radiation source; however, a liquid radiation source may also be used with a balloon catheter placed within a body cavity (e.g., lotrex ® , Proxima Therapeutics, Inc.). The radiation source may be removed following each treatment session, or may remain in place as long as the balloon remains within the body cavity.
  • Inflatable treatment delivery devices and systems such as the MammoSite ® RTS and similar devices and systems (e.g., GliaSite ® RTS (Proxima Therapeutics, Inc.)), are useful to treat cancer in tissue adjacent a body cavity.
  • MammoSite ® RTS and similar devices and systems (e.g., GliaSite ® RTS (Proxima Therapeutics, Inc.))
  • GliaSite ® RTS Proxima Therapeutics, Inc.
  • radiation, chemotherapy, thermal treatment, and other cancer treatments often have deleterious effects on healthy tissue in addition to the desired effects on cancerous tissue.
  • care must be taken to direct the maximum treatment effects to diseased tissue while minimizing its delivery or effects on healthy tissue.
  • radiation treatment may be most effective when all surrounding tissue regions receive the same dose of radiation, and where the radiation dosage received by more distant tissue is as small and as uniform as possible.
  • tissue cavities typically are not uniform or regular in their sizes and shapes, so that differences in dosages applied to different regions of surrounding tissue, including "hot spots" and regions of relatively low dosage, often result from radiation treatment.
  • the invention provides assemblies, devices, systems, and methods for treating tissue adjacent a body cavity, such as a cavity formed by the removal of tissue from a patient.
  • vacuum is applied effective to draw tissue towards a treatment assembly placed within the body cavity.
  • Assemblies and devices embodying features of the invention include a vacuum delivery element configured to apply a vacuum.
  • a vacuum delivery element may include a vacuum conduit, and may further include a vacuum port.
  • a vacuum delivery element may be configured to at least partially surround or enclose a treatment assembly.
  • a treatment assembly may be configured to deliver a treatment, such as radiation therapy, chemotherapy, thermal therapy, or other treatment, to tissue adjacent a body cavity.
  • a treatment assembly may include a treatment delivery element configured to contain a treatment material, such as a radioactive source.
  • a treatment assembly may include an inflatable balloon, which may be disposed at least in part around a treatment delivery element.
  • Assemblies and devices embodying features of the invention may include a vacuum delivery element such as a sheath or a balloon configured to provide vacuum effective to apply suction to tissue adjacent the assemblies and devices. Vacuum delivery elements are preferably configured to apply suction to tissue adjacent a treatment delivery assemblies, such as an inflatable treatment delivery device.
  • Suction is effective to draw surrounding tissue close to the surface of a treatment assembly, or to a vacuum delivery element (such as a sheath or balloon) at least partially surrounding or enclosing a treatment assembly, so as to shape the tissue lining the body cavity for optimal treatment.
  • Treatment may be by, e.g., radiation therapy, chemotherapy, thermal therapy, or other treatment modality supplied by the device.
  • a treatment assembly may include an inflatable treatment assembly such as an inner balloon assembly configured to be at least partly enclosed by a vacuum delivery element such as a sheath or balloon.
  • a sheath may be configured to at least partly enclose a balloon temporarily, following placement over or around an inner balloon.
  • a balloon may be configured to at least partly enclose a balloon permanently following placement over or around an inner balloon.
  • Devices may further include an enclosure assembly (which may comprise a sheath assembly or a balloon assembly) comprising a vacuum conduit and a fluid-permeable enclosure wall (e.g., a sheath wall or a balloon wall) configured to partly or completely enclose an inner balloon assembly.
  • an enclosure assembly may be effective to provide vacuum and a vacuum path to an intermediate space outside the inner balloon assembly.
  • An intermediate space may include a space disposed between the inner balloon assembly and a sheath assembly or an outer balloon assembly.
  • the enclosure assembly is preferably operatively connected to a vacuum conduit effective to provide vacuum to the intermediate space.
  • Systems having features of the invention include such devices and further include a vacuum source configured to operatively connect with the vacuum conduit.
  • a fluid- permeable enclosure wall may have a hole or multiple holes configured to allow passage of fluid, may be made with a fluid-permeable material, such as a fluid- permeable woven material, or may be otherwise fluid-permeable.
  • the space between the inner balloon and the enclosure may be prevented from collapse, even in the presence of suction from a vacuum delivered via the vacuum conduit, by separation elements disposed on the inner balloon wall, or on the enclosure wall, or both.
  • separation elements disposed within an intermediate space may be independent of both the inner balloon wall and the enclosure wall.
  • An embodiment of a device for treating tissue adjacent a body cavity having features of the invention further comprises an inner balloon assembly, which may include or be operatively connected with an inflation conduit configured to allow passage of a fluid.
  • Devices may also have an inner balloon comprising a distensible inner balloon wall defining an internal lumen.
  • Such an inner balloon may be operatively connected to an inflation conduit so as to allow for passage of fluid through an inflation conduit and into the internal lumen so as to inflate the inner balloon with the fluid.
  • An enclosure wall preferably comprises a flexible material, more preferably an elastic flexible material, although in embodiments of the invention, an eneclosure wall may comprise an inelastic flexible material.
  • an enclsoure wall comprises a polymer, such, as biocompatible polymer, preferably a radiation-resistant polymer.
  • Suitable polymers include polyolefins such as polyethylene and polypropylene, polyurethanes, polyester, polyvinylchloride, polystyrene, thermoplastic polymers such as C-Flex® (Consolidated Polymer Technologies, Inc., Clearwater FL 33762), block polymers such as KratonTM (Kraton Polymers, Houston TX 77208), an ionomer such as Surlyn® (Dupont, Wilmington DE 19880), nylon, latex rubber, and silicon rubber (e.g., SILASTICTM, Dow Corning, Midland, Ml).
  • Devices and systems having features of the invention include inner balloon assemblies configured to enclose a treatment material, such as radioactive material, chemotherapeutic agents, and thermal treatment materials (e.g., materials having a temperature greater than about 37 °C).
  • the invention further provides methods for treating tissue adjacent a body cavity, comprising contacting tissue adjacent a body cavity with a sheath or an outer balloon having a fluid-permeable wall of a device having features of the invention; and applying a vacuum effective to enhance the contact between the fluid- permeable wall and the tissue. Further methods may include delivering inflation fluid to an inner balloon lumen via an inflation conduit to inflate a distensible balloon.
  • the inner balloon assembly comprises a treatment assembly such as a Mammosite RTS or similar inflatable treatment delivery device. Methods may include placing a treatment material within the device, and may further include replacing the treatment material.
  • Body cavities are typically not uniform in size or regular in shape.
  • Devices, systems and methods having features of the invention utilize suction to draw tissue against the device surface within a body cavity, insuring good contact between the device and body tissue and providing control over the spacing between tissue and the device, including control over the distance from the treatment material contained within the devices.
  • Tissue lining a body cavity that is held close to, or in contact with, devices having features of the invention forms a uniform and controlled surface, unlike tissue lining a body cavity in which a prior art treatment device has been merely inserted, but which does not urge tissue into a desired orientation and position.
  • the control over the distance, spacing, and amount of tissue contact provided by devices, systems and methods of the present invention offer the advantages of improved treatment tissue adjacent a body cavity.
  • Figure 1 is partially cut-away perspective view of a system embodying features of the invention shown configured to deliver a treatment within a cavity in a patient's body tissue while providing vacuum effective to urge tissue into contact with an outer balloon surface.
  • Figure 2 is a longitudinal cross-sectional view of the system of Fig. 1 taken along line 2-2.
  • Figure 3 is a transverse cross-sectional view of the system of Fig. 1 taken along line 3-3.
  • Figure 4A is a cross-sectional view of a system of Fig. 1 showing a pie- shaped section of balloon walls between lines 4-4 for an embodiment in which an outer wall has stand-offs.
  • Figure 4B is a cross-sectional view of the system of Fig. 1 showing a pie-shaped section of balloon walls between lines 4-4 for an embodiment in which an inner wall has stand-offs.
  • Figure 5A shows a perspective view of a system embodying features of the invention in which an outer balloon assembly, in the form of a sheath, is being fitted over an inner balloon assembly.
  • Figure 5B shows a cross-sectional view of the assembled outer and inner balloon assemblies of Figure 5A following placement into a cavity within a breast of a patient and before inflation of the inner balloon assembly.
  • Figure 5C shows a cross-sectional view of the assembled outer and inner balloon assemblies of Figure 5A following inflation of the inner balloon assembly.
  • Figure 5D shows a cross-sectional view of the assembled outer and inner balloon assemblies of Figure 5A following application of vacuum to the lumen separating the inner balloon assembly and the outer balloon assembly, and after placement of a radioactive assembly within the inner balloon assembly.
  • Figure 6A is perspective view of a system embodying features of the invention including a vacuum delivery element configured to partly enclose an inner balloon assembly.
  • Figure 6B is a cross-sectional view of the system of Figure 6A taken along line 6B-6B.
  • the present invention provides devices and methods for delivering a treatment, such as a cancer treatment, into a cavity within the body of an animal.
  • a treatment such as a cancer treatment
  • devices and methods having features of the invention may be used to deliver treatments into a biopsy site or into a cavity left after removal of cancerous tissue from within the body of a human patient.
  • Vacuum is applied to tissue to enhance contact between a treatment delivery assembly within a body cavity and tissue surrounding the body cavity.
  • a vacuum path around the treatment assembly is provided by devices, systems and methods embodying features of the invention. Vacuum may be applied to tissue via one, two, or multiple vacuum ports.
  • a vacuum port may be a port in a vacuum delivery conduit, a hole in a sheath or balloon connected to a vacuum delivery conduit.
  • a fluid permeable wall or portion of a fluid permeable wall may be effective to serve as a vacuum port.
  • Figure 1 is a perspective view of a system 10 embodying features of the invention illustrating a device 12 having an outer balloon 14 enclosing an inner balloon 16 (shown in the cut-away portion of the illustration), a shaft 18 and connector 20.
  • Outer balloon 14 comprises a sheath assembly around inner balloon 16.
  • Outer balloon 14 is thus an example of an enclosure assembly, and forms an enclosure wall around inner balloon 16.
  • Outer balloon 14 comprises at least in part a fluid permeable wall; as illustrated in Figure 1 , outer balloon 14 has holes 22 allowing fluid permeation into and out of balloon 14.
  • an outer balloon 14 may be made of woven or otherwise substantially continuous materials that are fluid permeable.
  • an enclosure wall or assembly such as an outer balloon may comprise a net, mesh, framework, or other discontinuous structure. Holes 22 (or fluid permeable material) allows fluids to pass through outer balloon 14 into intermediate space 24 disposed outside inner balloon 16. Intermediate space 24 provides a vacuum path adjacent inner balloon 16. Where at least a portion of outer balloon 14 is disposed adjacent inner balloon 16, intermediate space 24 is disposed between outer balloon 14 and inner balloon 16.
  • Inner balloon 16 defines an inner lumen 26, within which a delivery shaft 28 may be at least partially contained.
  • a treatment material 30 may be permanently or transiently disposed within delivery shaft 28.
  • a probe 32 configured to move within delivery shaft 28 may be used to position treatment material 30, including to place treatment material 30 into and to retrieve placement material 30 from, within delivery shaft 28.
  • a vacuum conduit 34 may be part of, or may be contained within, a shaft 18 and operatively connected to intermediate space 24.
  • Shaft 18 may also include or contain an inflation conduit 36 configured to allow passage of inflation fluid into inner lumen 26. Passage of inflation fluid into inner lumen 26 is effective to inflate inner balloon 16.
  • Inflation fluid may be any suitable fluid, either a gas or a liquid, and is typically inert.
  • Inflation fluid where a gas, may be, e.g., air, nitrogen, carbon dioxide or other gas.
  • Inflation fluid where a liquid, may be water, saline, mineral oil, or other liquid.
  • an inflation fluid may be effective to absorb radiation to, for example, moderate or adjust a dosage of radiation delivered to a patient's tissue from radioactive treatment material 30 contained within a delivery shaft 28.
  • Vacuum applied to intermediate space 24 is effective to deliver a treatment within a body cavity 38 within a patient's body effective to urge surrounding tissue into contact with at least a portion of the surface of the outer balloon 14.
  • the outer balloon 14 shown in Figs. 1-5 is illustrated as a balloon that is configured to permanently or semi-permanently enclose inner balloon 16 or inner balloon assembly. Such an enclosure may be partial or complete. It will be understood that the outer surface of a device and of a system embodying features of the invention may also be a sheath 50 configured for deployment over and around an inner balloon assembly 14. In further embodiments, an enclosure may be, e.g. a net, mesh, framework, or other discontinuous structure.
  • Figure 2 is a longitudinal cross-sectional view of the system of Fig. 1 taken along line 2-2 showing in cross section, for example, the relative positions of treatment material 30, an inner balloon 16, and an outer balloon 14 or sheath 50.
  • Figure 2 includes cross-sectional views of shaft 18 including views of delivery shaft 28, vacuum conduit 34 and inflation conduit 36.
  • Figure 3 is a transverse cross- sectional view of the system of Fig. 1 taken along line 3-3 showing outer balloon 14 and holes 22 therethrough, inner balloon 16 disposed within outer balloon 14, delivery shaft 28 and probe 32.
  • Figure 4A and 4B show portions of outer balloon 14 and inner balloon
  • Spacers 40 may be part of outer balloon 14, or of inner balloon 16, or both.
  • a spacer 40 may be a bump, knob, ridge, or other feature extending inwardly from an inner surface 42 of outer balloon 14, or extending outwardly from an outer surface 44 of outer balloon 14.
  • a spacer 40 may be an object that is placed within intermediate space 24 and is separate from outer balloon 14 and inner balloon 16.
  • spacers 40 may be stand-offs extending from an inner surface 42 of outer balloon 14 and from an outer surface 44 of outer balloon 14.
  • Figures 5A-5D illustrate the fitting of an outer balloon assembly 46
  • FIG. 5B shows the assembled outer 46 and inner 48 balloon assemblies of Figure 6A following placement into a cavity 38 within a breast 52 of a patient and before inflation of the inner balloon assembly 48.
  • the inner balloon assembly 48 has been inflated by passage of inflation fluid through inflation conduit 36, pressing some parts of the outer surface 54 outer balloon assembly 46 into contact with portions of the inner surface 56 of body cavity 38. Note, however, that since most cavities 38 have irregular inner surfaces 56, there will typically be poor and intermittent contact between outer surface 54 of sheath 50 (or outer balloon 14 in alternative embodiments) and inner surface 56 of cavity 38, as shown in Figure 5C.
  • FIG. 5D shows the assembled outer 46 and inner 48 balloon assemblies of Figure 5A following application of vacuum via vacuum conduit 34 to the intermediate space 24 separating the inner balloon 16 and the sheath 50 (outer balloon 14).
  • Treatment material 30 is in place within delivery shaft 28.
  • inner surface 56 of cavity 38 has been pulled into intimate contact with outer surface 54 of sheath 50.
  • Such intimate contact configures inner surface 56 into an optimal configuration for the application of treatment by a treatment material 30.
  • radiation treatment by a radiation treatment material 30 is enhanced by proper positioning of adjacent tissue to provide proper irradiation. Irradiation levels may vary widely where the adjacent tissue of tissue cavity 38 is at different, irregular, or improper distances from a radiation source.
  • Application of vacuum effective to draw tissue into better contact with device 12, e.g., into better contact with outer surface 54 of sheath 50, is effective to improve the delivery of radiation treatment from a radioactive treatment material 30.
  • FIG. 6A illustrates a system embodying features of the invention including a vacuum delivery element comprising an enclosure 60 having ribs 62 configured to partly enclose an inner balloon assembly 48. Vacuum is delivered to intermediate space 24 via vacuum ports 64 operatively connected to vacuum conduit 34. As shown in cross-section in Figure 6B, ribs 62 serve as separation elements effective to provide vacuum paths in the intermediate space 24 between tissue surface 56 and outer surface 44 of inner balloon assembly 48.
  • Methods for treating tissue adjacent a body cavity 38 include methods for delivering a treatment to tissue adjacent a device 12 embodying features of the invention.
  • a method of treating tissue adjacent a body cavity 38 includes contacting tissue adjacent the body cavity 38 with a sheath 50 or an outer balloon 14, and applying a vacuum via vacuum conduit 34.
  • the vacuum may be effective to draw adjacent tissue towards and into contact with a sheath 50 or an outer balloon 14, and so enhance the contact between the outer wall 54 and the tissue.
  • Delivery of inflation fluid to an inner balloon 16 via an inflation conduit 36 to inflate inner balloon 16 is effective to enhance contact with adjacent tissue as well, serving to bring outer balloon 14 or sheath 50 closer to tissue than it would be in the absence of inflation of inner balloon 16.
  • the inner balloon assembly 48 comprises an inflatable treatment delivery device such as a Mammosite RTS (Proxima Therapeutics, Inc., Alpharetta, GA 30005) or similar device.
  • Methods further include placing a treatment material 30, such as a radiation source, within the device (e.g., by placement within a delivery shaft 28).
  • a radiation source such as a solid radiation source (e.g., a brachytherapy seeds) may be advanced into a delivery shaft 28 with a probe 32 or by other means.
  • Other solid treatment materials 30 may similarly be advanced into a delivery shaft 28 with a probe 32 or by other means.
  • a liquid radiation source e.g., lotrex ® , Proxima Therapeutics, Inc., Alpharetta, GA
  • a liquid radiation source may be advanced into a delivery shaft 28 by fluid flow, under the influence of gravity, pressure applied by a syringe or other pressure source, or other means for delivering fluid into a space.
  • hot liquids and other liquid treatment materials 30 may be introduced into a delivery shaft 28 or an inner balloon 16 (via inflation conduit 36) under the influence of gravity, pressure applied by a syringe or other pressure source, or other means for delivering fluid into a space.
  • Some treatment regimens may include periodic or episodic treatment, in which radiation or other treatment is applied for a treatment period, and then the treatment is stopped for a recovery period. Such periodic or episodic treatments may be repeated, so that treatment is applied during a first treatment period, stopped during a first recovery period, and then treatment is re-applied for a second treatment period. Further treatment periods and recovery periods may also be used as necessary. Thus, methods may further include removal of a radiation source or other treatment material 30 from within a delivery shaft 28, and may further include replacing the treatment material 30.
  • a body cavity 38 is typically an artificial cavity remaining after removal of tissue at biopsy, surgery, or other medical procedure
  • a body cavity may be a natural body cavity.
  • devices 12 may be inserted into a bladder for the treatment of bladder cancer.
  • Application of suction is effective to enhance contact with a device 12 in such an example as well.
  • Such enhanced contact may be effective to improve the delivery of radiation or other treatment, and may be effective to avoid "hot spots" (tissue regions receiving more radiation than is received by neighboring tissue regions) and is one of the important advantages provided by the present invention.
  • Treatment material 30 may include a chemotherapy agent effective to treat cancer or other disease condition of tissue surrounding a body cavity 38.
  • treatment material 30 includes a radiation source configured to delivery radiation to tissue adjacent a device 12.
  • treatment material 30 may include a radiation source which may be solid or liquid.
  • a liquid radiation source may include, for example, a liquid containing a radioactive iodine isotope (e.g., 125 l or 131 l), a slurry of a solid isotope, e.g. 198 AU, 90 Y, 169 Yb, or a gel containing a radioactive isotope.
  • Liquid radiation sources are commercially available (e.g., lotrex ® , Proxima Therapeutics, Inc., Alpharetta, GA).
  • a solid radiation source may include brachytherapy seeds or other solid radiation source used in radiation therapy, such as, for example, a radioactive microsphere available from the 3M company of St. Paul, MN.
  • a solid radioactive source can either be preloaded into a device 12 at the time of manufacture or may be loaded into the device 12 after placement into body cavity 38 of a distal portion of the device 12. Such distal portion preferably includes the outer balloon 14, inner balloon 16, and at least a portion of delivery shaft 28.
  • Such a solid radioactive core configuration offers the advantage in that it allows a wider range of radionuclides than if one is limited to liquids.
  • Solid radionuclides suitable for use with a delivery device embodying features of the present invention are currently generally available as brachytherapy radiation sources (e.g., I-PlantTM, Med-Tec, Orange City IA).
  • brachytherapy radiation sources e.g., I-PlantTM, Med-Tec, Orange City IA.
  • the amount of radiation desired by the physician is a certain minimum amount that is delivered to a site about 0-3 cm away from the wall of the body cavity 38 (e.g., from where a tumor has been excised).
  • Vacuum applied to intermediate space 24 effects good contact between tissue surrounding body cavity 38 and the wall of the outer balloon 14 or sheath 50, promoting effective treatment delivery, such as delivery of radiation to surrounding tissue.
  • An inflation fluid may also be a radiation absorbing fluid.
  • an inflation fluid may be an X-ray contrast agent as used in angiography, such as a Barium salt (e.g., barium sulfate), water, saline or other such fluid.
  • a radiation- absorbing inflation fluid which will surround a radiation source placed within delivery shaft 28, serves to moderate and control the delivery of radiation from the radiation source to surrounding tissue. Such moderation and control that is obtained with a radiation-absorbing inflation fluid may aid in avoiding the delivery of an excessive amount of radiation to some portions of the surrounding tissue.
  • an inflation fluid may contain radioactive elements, either as a liquid or slurry, so that the inner balloon 16 is filled with a source of radiation, providing a fairly uniform source of radiation that is distributed over the volume of the inner balloon 16.
  • an inflation fluid thus itself serves as a radiation source, thereby providing well-controlled amounts of radiation to surrounding tissue while minimizing irregularities in the dosages delivered to particular locations.
  • a delivery shaft 28 may contain a radiation absorptive material, so that, for example, less volume of radioactive material is required than if the entire volume of a device 12 were filled with radioactive material.
  • a radiation absorptive material such as, for example, less volume of radioactive material is required than if the entire volume of a device 12 were filled with radioactive material.
  • Such a configuration may be advantageous where a profile exhibiting higher intensity at a tissue surface with lesser penetration is desired.
  • the outer balloon 14 need not be spherical, yet a uniform profile of radiation delivery is obtainable.
  • 5,918,813 are described as showing that a steeper radial absorbed source gradient can be obtained using a radiation attenuation fluid in an inner chamber of a similar radiation deliver device than otherwise obtains with a device having only a single distensible chamber (as described in Williams U.S. Pat. No. 5,429,582).

Abstract

Devices and methods are provided for applying vacuum near to devices for delivering treatments to tissue adjacent a body cavity, effective to draw adjacent tissue near to such devices and to enhance treatment of the tissue. Body cavities include natural body cavities and cavities remaining after removal of tissue such as cancerous tissue. A device may include an inner balloon assembly with an inflation conduit. A sheath assembly having a fluid-permeable sheath wall may enclose the inner balloon assembly. Vacuum applied to the space between the sheath and the inner balloon is useful to draw tissue into contact with the device, improving treatment effectiveness. Methods for treating tissue with such devices and systems are also provided. Treatment may include providing radioactive material for radiation treatment, providing chemotherapeutic material for chemotherapy, providing thermal treatment, and combinations thereof. Systems may include devices of the invention and a vacuum source.

Description

VACUUM DEVICE AND METHOD FOR TREATING TISSUE ADJACENT A BODY
CAVITY
FIELD OF THE INVENTION [0001] This invention relates generally to the fields of medical treatment devices and methods. In particular, the invention relates to devices and methods for treating tissue surrounding a body cavity, such as a site from which cancerous, pre- cancerous, or other tissue has been removed.
BACKGROUND OF THE INVENTION [0002] In diagnosing and treating certain medical conditions, it is often desirable to perform a biopsy, in which a specimen or sample of tissue is removed for pathological examination, tests and analysis. A biopsy typically results in a biopsy cavity occupying the space formerly occupied by the tissue that was removed. As is known, obtaining a tissue sample by biopsy and the subsequent examination are typically employed in the diagnosis of cancers and other malignant tumors, or to confirm that a suspected lesion or tumor is not malignant. Treatment of cancers identified by biopsy may include subsequent removal of tissue surrounding the biopsy site, leaving an enlarged cavity in the patient's body. Cancerous tissue is often treated by application of radiation, by chemotherapy, or by thermal treatment (e.g., local heating, cryogenic therapy, and other treatments to heat, cool, or freeze tissue).
[0003] Cancer treatment may be directed to a natural cavity, or to a cavity in a patient's body from which tissue has been removed, typically following removal of cancerous tissue during a biopsy or surgical procedure. For example, U.S. Patent 5,429,582 to Williams, U.S. Patent 5,913,813 to Williams et al., U.S. Patent 5,931 ,774 to Williams et al., U.S. Patent 6,022,308 to Williams, U.S. Patent 6,083,148 to Williams, and U.S. Patent 6,413,204 to Winkler et al., the disclosures of which are all hereby incorporated by reference in their entireties, describe devices for implantation into a cavity resulting from the removal of cancerous tissue which can be used to deliver cancer treatments to surrounding tissue. One form of radiation treatment used to treat cancer near a body cavity remaining following removal of tissue is "brachytherapy" in which a source of radiation is placed near to the site to be treated.
[0004] Williams and coworkers describe implantable devices for treating tissue surrounding a cavity left by surgical removal of cancerous or other tissue that includes an inflatable balloon constructed for placement in the cavity. Such devices may be used to apply one or more of radiation therapy, chemotherapy, and thermal therapy to the tissue surrounding the cavity from which the tissue was removed. The balloon may be filled with a treatment fluid delivered via a conduit from a receptacle, syringe, or other means, or may receive a solid radiation source placed within the balloon. Thus, radiation treatment may be applied to tissue adjacent the balloon by placing radioactive material such as radioactive "seeds" within the balloon, or by filling the balloon with a liquid or slurry containing radioactive material. Multiple treatments may be applied simultaneously. For example, radioactive seeds may be placed within the balloon effective to irradiate tissue surrounding the balloon, and the balloon filled with a hot fluid at the same time to provide thermal treatment. After a suitable time, the hot fluid and/or the radioactive seeds may be removed. Such treatments, combined or otherwise, may be repeated if desired. [0005] For example, a "MammoSite® Radiation Therapy System"
(MammoSite® RTS, Proxima Therapeutics, Inc., Alpharetta, GA 30005 USA) includes a balloon catheter with a radiation source that can be placed within a tumor resection cavity in a breast after a lumpectomy. It can deliver a prescribed dose of radiation from inside the tumor resection cavity to the tissue surrounding the original tumor. The radiation source is typically a solid radiation source; however, a liquid radiation source may also be used with a balloon catheter placed within a body cavity (e.g., lotrex®, Proxima Therapeutics, Inc.). The radiation source may be removed following each treatment session, or may remain in place as long as the balloon remains within the body cavity. Inflatable treatment delivery devices and systems, such as the MammoSite® RTS and similar devices and systems (e.g., GliaSite® RTS (Proxima Therapeutics, Inc.)), are useful to treat cancer in tissue adjacent a body cavity.
[0006] However, radiation, chemotherapy, thermal treatment, and other cancer treatments often have deleterious effects on healthy tissue in addition to the desired effects on cancerous tissue. In such treatments, care must be taken to direct the maximum treatment effects to diseased tissue while minimizing its delivery or effects on healthy tissue. For example, radiation treatment may be most effective when all surrounding tissue regions receive the same dose of radiation, and where the radiation dosage received by more distant tissue is as small and as uniform as possible. However, tissue cavities typically are not uniform or regular in their sizes and shapes, so that differences in dosages applied to different regions of surrounding tissue, including "hot spots" and regions of relatively low dosage, often result from radiation treatment.
[0007] Thus, there is need in the art for improved devices and methods for delivering cancer treatment to a cavity site within a patient's body. SUMMARY OF THE INVENTION [0008] The invention provides assemblies, devices, systems, and methods for treating tissue adjacent a body cavity, such as a cavity formed by the removal of tissue from a patient. In methods and devices having features of the invention, vacuum is applied effective to draw tissue towards a treatment assembly placed within the body cavity. Assemblies and devices embodying features of the invention include a vacuum delivery element configured to apply a vacuum. A vacuum delivery element may include a vacuum conduit, and may further include a vacuum port. A vacuum delivery element may be configured to at least partially surround or enclose a treatment assembly. A treatment assembly may be configured to deliver a treatment, such as radiation therapy, chemotherapy, thermal therapy, or other treatment, to tissue adjacent a body cavity. A treatment assembly may include a treatment delivery element configured to contain a treatment material, such as a radioactive source. A treatment assembly may include an inflatable balloon, which may be disposed at least in part around a treatment delivery element. [0009] Assemblies and devices embodying features of the invention may include a vacuum delivery element such as a sheath or a balloon configured to provide vacuum effective to apply suction to tissue adjacent the assemblies and devices. Vacuum delivery elements are preferably configured to apply suction to tissue adjacent a treatment delivery assemblies, such as an inflatable treatment delivery device. Suction is effective to draw surrounding tissue close to the surface of a treatment assembly, or to a vacuum delivery element (such as a sheath or balloon) at least partially surrounding or enclosing a treatment assembly, so as to shape the tissue lining the body cavity for optimal treatment. Treatment may be by, e.g., radiation therapy, chemotherapy, thermal therapy, or other treatment modality supplied by the device. A treatment assembly may include an inflatable treatment assembly such as an inner balloon assembly configured to be at least partly enclosed by a vacuum delivery element such as a sheath or balloon. A sheath may be configured to at least partly enclose a balloon temporarily, following placement over or around an inner balloon. A balloon may be configured to at least partly enclose a balloon permanently following placement over or around an inner balloon. [0010] Devices may further include an enclosure assembly (which may comprise a sheath assembly or a balloon assembly) comprising a vacuum conduit and a fluid-permeable enclosure wall (e.g., a sheath wall or a balloon wall) configured to partly or completely enclose an inner balloon assembly. Such an enclosure assembly may be effective to provide vacuum and a vacuum path to an intermediate space outside the inner balloon assembly. An intermediate space may include a space disposed between the inner balloon assembly and a sheath assembly or an outer balloon assembly. The enclosure assembly is preferably operatively connected to a vacuum conduit effective to provide vacuum to the intermediate space. Systems having features of the invention include such devices and further include a vacuum source configured to operatively connect with the vacuum conduit. In embodiments of devices having features of the invention, a fluid- permeable enclosure wall may have a hole or multiple holes configured to allow passage of fluid, may be made with a fluid-permeable material, such as a fluid- permeable woven material, or may be otherwise fluid-permeable. The space between the inner balloon and the enclosure may be prevented from collapse, even in the presence of suction from a vacuum delivered via the vacuum conduit, by separation elements disposed on the inner balloon wall, or on the enclosure wall, or both. In alternative embodiments, separation elements disposed within an intermediate space may be independent of both the inner balloon wall and the enclosure wall.
[0011] An embodiment of a device for treating tissue adjacent a body cavity having features of the invention further comprises an inner balloon assembly, which may include or be operatively connected with an inflation conduit configured to allow passage of a fluid. Devices may also have an inner balloon comprising a distensible inner balloon wall defining an internal lumen. Such an inner balloon may be operatively connected to an inflation conduit so as to allow for passage of fluid through an inflation conduit and into the internal lumen so as to inflate the inner balloon with the fluid.
[0012] An enclosure wall preferably comprises a flexible material, more preferably an elastic flexible material, although in embodiments of the invention, an eneclosure wall may comprise an inelastic flexible material. In embodiments of devices and systems having features of the invention, an enclsoure wall comprises a polymer, such, as biocompatible polymer, preferably a radiation-resistant polymer. Suitable polymers include polyolefins such as polyethylene and polypropylene, polyurethanes, polyester, polyvinylchloride, polystyrene, thermoplastic polymers such as C-Flex® (Consolidated Polymer Technologies, Inc., Clearwater FL 33762), block polymers such as Kraton™ (Kraton Polymers, Houston TX 77208), an ionomer such as Surlyn® (Dupont, Wilmington DE 19880), nylon, latex rubber, and silicon rubber (e.g., SILASTIC™, Dow Corning, Midland, Ml).
[0013] Devices and systems having features of the invention include inner balloon assemblies configured to enclose a treatment material, such as radioactive material, chemotherapeutic agents, and thermal treatment materials (e.g., materials having a temperature greater than about 37 °C). [0014] The invention further provides methods for treating tissue adjacent a body cavity, comprising contacting tissue adjacent a body cavity with a sheath or an outer balloon having a fluid-permeable wall of a device having features of the invention; and applying a vacuum effective to enhance the contact between the fluid- permeable wall and the tissue. Further methods may include delivering inflation fluid to an inner balloon lumen via an inflation conduit to inflate a distensible balloon. In embodiments of the methods of the invention, the inner balloon assembly comprises a treatment assembly such as a Mammosite RTS or similar inflatable treatment delivery device. Methods may include placing a treatment material within the device, and may further include replacing the treatment material.
[0015] Body cavities are typically not uniform in size or regular in shape.
Devices, systems and methods having features of the invention utilize suction to draw tissue against the device surface within a body cavity, insuring good contact between the device and body tissue and providing control over the spacing between tissue and the device, including control over the distance from the treatment material contained within the devices. Tissue lining a body cavity that is held close to, or in contact with, devices having features of the invention forms a uniform and controlled surface, unlike tissue lining a body cavity in which a prior art treatment device has been merely inserted, but which does not urge tissue into a desired orientation and position. The control over the distance, spacing, and amount of tissue contact provided by devices, systems and methods of the present invention offer the advantages of improved treatment tissue adjacent a body cavity. Such improvements may include more uniform dosing, reduction of "hot spots," shorter treatments due greater correlation between desired and actual dosages, and reduction in the number of locations receiving inadequate dosages. BRIEF DESCRIPTION OF THE DRAWINGS [0016] Figure 1 is partially cut-away perspective view of a system embodying features of the invention shown configured to deliver a treatment within a cavity in a patient's body tissue while providing vacuum effective to urge tissue into contact with an outer balloon surface.
[0017] Figure 2 is a longitudinal cross-sectional view of the system of Fig. 1 taken along line 2-2.
[0018] Figure 3 is a transverse cross-sectional view of the system of Fig. 1 taken along line 3-3.
[0019] Figure 4A is a cross-sectional view of a system of Fig. 1 showing a pie- shaped section of balloon walls between lines 4-4 for an embodiment in which an outer wall has stand-offs.
[0020] Figure 4B is a cross-sectional view of the system of Fig. 1 showing a pie-shaped section of balloon walls between lines 4-4 for an embodiment in which an inner wall has stand-offs.
[0021] Figure 5A shows a perspective view of a system embodying features of the invention in which an outer balloon assembly, in the form of a sheath, is being fitted over an inner balloon assembly.
[0022] Figure 5B shows a cross-sectional view of the assembled outer and inner balloon assemblies of Figure 5A following placement into a cavity within a breast of a patient and before inflation of the inner balloon assembly. [0023] Figure 5C shows a cross-sectional view of the assembled outer and inner balloon assemblies of Figure 5A following inflation of the inner balloon assembly. [0024] Figure 5D shows a cross-sectional view of the assembled outer and inner balloon assemblies of Figure 5A following application of vacuum to the lumen separating the inner balloon assembly and the outer balloon assembly, and after placement of a radioactive assembly within the inner balloon assembly.
[0025] Figure 6A is perspective view of a system embodying features of the invention including a vacuum delivery element configured to partly enclose an inner balloon assembly.
[0026] Figure 6B is a cross-sectional view of the system of Figure 6A taken along line 6B-6B.
DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS [0027] The present invention provides devices and methods for delivering a treatment, such as a cancer treatment, into a cavity within the body of an animal. For example, devices and methods having features of the invention may be used to deliver treatments into a biopsy site or into a cavity left after removal of cancerous tissue from within the body of a human patient. Vacuum is applied to tissue to enhance contact between a treatment delivery assembly within a body cavity and tissue surrounding the body cavity. A vacuum path around the treatment assembly is provided by devices, systems and methods embodying features of the invention. Vacuum may be applied to tissue via one, two, or multiple vacuum ports. A vacuum port may be a port in a vacuum delivery conduit, a hole in a sheath or balloon connected to a vacuum delivery conduit. A fluid permeable wall or portion of a fluid permeable wall may be effective to serve as a vacuum port. [0028] Figure 1 is a perspective view of a system 10 embodying features of the invention illustrating a device 12 having an outer balloon 14 enclosing an inner balloon 16 (shown in the cut-away portion of the illustration), a shaft 18 and connector 20. Outer balloon 14 comprises a sheath assembly around inner balloon 16. Outer balloon 14 is thus an example of an enclosure assembly, and forms an enclosure wall around inner balloon 16. Outer balloon 14 comprises at least in part a fluid permeable wall; as illustrated in Figure 1 , outer balloon 14 has holes 22 allowing fluid permeation into and out of balloon 14. In alternative embodiments, an outer balloon 14 may be made of woven or otherwise substantially continuous materials that are fluid permeable. In further embodiments, an enclosure wall or assembly such as an outer balloon may comprise a net, mesh, framework, or other discontinuous structure. Holes 22 (or fluid permeable material) allows fluids to pass through outer balloon 14 into intermediate space 24 disposed outside inner balloon 16. Intermediate space 24 provides a vacuum path adjacent inner balloon 16. Where at least a portion of outer balloon 14 is disposed adjacent inner balloon 16, intermediate space 24 is disposed between outer balloon 14 and inner balloon 16. [0029] Inner balloon 16 defines an inner lumen 26, within which a delivery shaft 28 may be at least partially contained. As shown in Figure 2, a treatment material 30 may be permanently or transiently disposed within delivery shaft 28. A probe 32 configured to move within delivery shaft 28 may be used to position treatment material 30, including to place treatment material 30 into and to retrieve placement material 30 from, within delivery shaft 28. A vacuum conduit 34 may be part of, or may be contained within, a shaft 18 and operatively connected to intermediate space 24. Shaft 18 may also include or contain an inflation conduit 36 configured to allow passage of inflation fluid into inner lumen 26. Passage of inflation fluid into inner lumen 26 is effective to inflate inner balloon 16. Inflation fluid may be any suitable fluid, either a gas or a liquid, and is typically inert. Inflation fluid, where a gas, may be, e.g., air, nitrogen, carbon dioxide or other gas. Inflation fluid, where a liquid, may be water, saline, mineral oil, or other liquid. In some embodiment, an inflation fluid may be effective to absorb radiation to, for example, moderate or adjust a dosage of radiation delivered to a patient's tissue from radioactive treatment material 30 contained within a delivery shaft 28. [0030] Vacuum applied to intermediate space 24 is effective to deliver a treatment within a body cavity 38 within a patient's body effective to urge surrounding tissue into contact with at least a portion of the surface of the outer balloon 14.
[0031] The outer balloon 14 shown in Figs. 1-5 is illustrated as a balloon that is configured to permanently or semi-permanently enclose inner balloon 16 or inner balloon assembly. Such an enclosure may be partial or complete. It will be understood that the outer surface of a device and of a system embodying features of the invention may also be a sheath 50 configured for deployment over and around an inner balloon assembly 14. In further embodiments, an enclosure may be, e.g. a net, mesh, framework, or other discontinuous structure.
[0032] Figure 2 is a longitudinal cross-sectional view of the system of Fig. 1 taken along line 2-2 showing in cross section, for example, the relative positions of treatment material 30, an inner balloon 16, and an outer balloon 14 or sheath 50. Figure 2 includes cross-sectional views of shaft 18 including views of delivery shaft 28, vacuum conduit 34 and inflation conduit 36. Figure 3 is a transverse cross- sectional view of the system of Fig. 1 taken along line 3-3 showing outer balloon 14 and holes 22 therethrough, inner balloon 16 disposed within outer balloon 14, delivery shaft 28 and probe 32.
[0033] Figure 4A and 4B show portions of outer balloon 14 and inner balloon
16 as indicated in Figure 1 , including intermediate space 24 and spacers 40 which serve as separation elements effective to maintain patency of intermediate space 24 even under the influence of vacuum supplied via vacuum conduit 34. Spacers 40 may be part of outer balloon 14, or of inner balloon 16, or both. A spacer 40 may be a bump, knob, ridge, or other feature extending inwardly from an inner surface 42 of outer balloon 14, or extending outwardly from an outer surface 44 of outer balloon 14. In addition, or alternatively, a spacer 40 may be an object that is placed within intermediate space 24 and is separate from outer balloon 14 and inner balloon 16. For example, as shown in Figures 4A and 4B, spacers 40 may be stand-offs extending from an inner surface 42 of outer balloon 14 and from an outer surface 44 of outer balloon 14.
[0034] Figures 5A-5D illustrate the fitting of an outer balloon assembly 46
(including an outer balloon in the form of a sheath 50), over an inner balloon assembly 48 including an inner balloon 16. Figure 5B shows the assembled outer 46 and inner 48 balloon assemblies of Figure 6A following placement into a cavity 38 within a breast 52 of a patient and before inflation of the inner balloon assembly 48. In Figure 5C, the inner balloon assembly 48 has been inflated by passage of inflation fluid through inflation conduit 36, pressing some parts of the outer surface 54 outer balloon assembly 46 into contact with portions of the inner surface 56 of body cavity 38. Note, however, that since most cavities 38 have irregular inner surfaces 56, there will typically be poor and intermittent contact between outer surface 54 of sheath 50 (or outer balloon 14 in alternative embodiments) and inner surface 56 of cavity 38, as shown in Figure 5C.
[0035] Figure 5D shows the assembled outer 46 and inner 48 balloon assemblies of Figure 5A following application of vacuum via vacuum conduit 34 to the intermediate space 24 separating the inner balloon 16 and the sheath 50 (outer balloon 14). Treatment material 30 is in place within delivery shaft 28. Note that inner surface 56 of cavity 38 has been pulled into intimate contact with outer surface 54 of sheath 50. Such intimate contact configures inner surface 56 into an optimal configuration for the application of treatment by a treatment material 30. For example, radiation treatment by a radiation treatment material 30 is enhanced by proper positioning of adjacent tissue to provide proper irradiation. Irradiation levels may vary widely where the adjacent tissue of tissue cavity 38 is at different, irregular, or improper distances from a radiation source. Application of vacuum effective to draw tissue into better contact with device 12, e.g., into better contact with outer surface 54 of sheath 50, is effective to improve the delivery of radiation treatment from a radioactive treatment material 30.
[0036] Figure 6A illustrates a system embodying features of the invention including a vacuum delivery element comprising an enclosure 60 having ribs 62 configured to partly enclose an inner balloon assembly 48. Vacuum is delivered to intermediate space 24 via vacuum ports 64 operatively connected to vacuum conduit 34. As shown in cross-section in Figure 6B, ribs 62 serve as separation elements effective to provide vacuum paths in the intermediate space 24 between tissue surface 56 and outer surface 44 of inner balloon assembly 48. [0037] Methods for treating tissue adjacent a body cavity 38 include methods for delivering a treatment to tissue adjacent a device 12 embodying features of the invention. For example, a method of treating tissue adjacent a body cavity 38 includes contacting tissue adjacent the body cavity 38 with a sheath 50 or an outer balloon 14, and applying a vacuum via vacuum conduit 34. The vacuum may be effective to draw adjacent tissue towards and into contact with a sheath 50 or an outer balloon 14, and so enhance the contact between the outer wall 54 and the tissue. Delivery of inflation fluid to an inner balloon 16 via an inflation conduit 36 to inflate inner balloon 16 is effective to enhance contact with adjacent tissue as well, serving to bring outer balloon 14 or sheath 50 closer to tissue than it would be in the absence of inflation of inner balloon 16. In preferred embodiments, the inner balloon assembly 48 comprises an inflatable treatment delivery device such as a Mammosite RTS (Proxima Therapeutics, Inc., Alpharetta, GA 30005) or similar device. [0038] Methods further include placing a treatment material 30, such as a radiation source, within the device (e.g., by placement within a delivery shaft 28). A radiation source, such as a solid radiation source (e.g., a brachytherapy seeds) may be advanced into a delivery shaft 28 with a probe 32 or by other means. Other solid treatment materials 30 may similarly be advanced into a delivery shaft 28 with a probe 32 or by other means. A liquid radiation source (e.g., lotrex®, Proxima Therapeutics, Inc., Alpharetta, GA) may be advanced into a delivery shaft 28 by fluid flow, under the influence of gravity, pressure applied by a syringe or other pressure source, or other means for delivering fluid into a space. Similarly, hot liquids and other liquid treatment materials 30 may be introduced into a delivery shaft 28 or an inner balloon 16 (via inflation conduit 36) under the influence of gravity, pressure applied by a syringe or other pressure source, or other means for delivering fluid into a space.
[0039] Some treatment regimens may include periodic or episodic treatment, in which radiation or other treatment is applied for a treatment period, and then the treatment is stopped for a recovery period. Such periodic or episodic treatments may be repeated, so that treatment is applied during a first treatment period, stopped during a first recovery period, and then treatment is re-applied for a second treatment period. Further treatment periods and recovery periods may also be used as necessary. Thus, methods may further include removal of a radiation source or other treatment material 30 from within a delivery shaft 28, and may further include replacing the treatment material 30.
[0040] Although a cavity 38 is typically an artificial cavity remaining after removal of tissue at biopsy, surgery, or other medical procedure, a body cavity may be a natural body cavity. For example, devices 12 may be inserted into a bladder for the treatment of bladder cancer. Application of suction is effective to enhance contact with a device 12 in such an example as well. Such enhanced contact may be effective to improve the delivery of radiation or other treatment, and may be effective to avoid "hot spots" (tissue regions receiving more radiation than is received by neighboring tissue regions) and is one of the important advantages provided by the present invention.
[0041] Treatment material 30 may include a chemotherapy agent effective to treat cancer or other disease condition of tissue surrounding a body cavity 38. In preferred embodiments, treatment material 30 includes a radiation source configured to delivery radiation to tissue adjacent a device 12.
[0042] Thus, treatment material 30 may include a radiation source which may be solid or liquid. A liquid radiation source may include, for example, a liquid containing a radioactive iodine isotope (e.g., 125l or 131l), a slurry of a solid isotope, e.g. 198AU, 90Y, 169Yb, or a gel containing a radioactive isotope. Liquid radiation sources are commercially available (e.g., lotrex®, Proxima Therapeutics, Inc., Alpharetta, GA).
[0043] A solid radiation source may include brachytherapy seeds or other solid radiation source used in radiation therapy, such as, for example, a radioactive microsphere available from the 3M company of St. Paul, MN. A solid radioactive source can either be preloaded into a device 12 at the time of manufacture or may be loaded into the device 12 after placement into body cavity 38 of a distal portion of the device 12. Such distal portion preferably includes the outer balloon 14, inner balloon 16, and at least a portion of delivery shaft 28. Such a solid radioactive core configuration offers the advantage in that it allows a wider range of radionuclides than if one is limited to liquids. Solid radionuclides suitable for use with a delivery device embodying features of the present invention are currently generally available as brachytherapy radiation sources (e.g., I-Plant™, Med-Tec, Orange City IA). [0044] In general, the amount of radiation desired by the physician is a certain minimum amount that is delivered to a site about 0-3 cm away from the wall of the body cavity 38 (e.g., from where a tumor has been excised). Vacuum applied to intermediate space 24 effects good contact between tissue surrounding body cavity 38 and the wall of the outer balloon 14 or sheath 50, promoting effective treatment delivery, such as delivery of radiation to surrounding tissue. It is desirable to keep the radiation in the region near the wall of the outer balloon 14 or sheath 50 as uniform as possible to prevent over-exposure to tissue at or near the reservoir wall. It is well known that the absorbed dose rate at a point exterior to a radioactive source is inversely proportional to the square of the distance between the radiation source and the target point. Thus, it is possible that the radiation dosage delivered to adjacent tissue may differ from that delivered to tissue disposed at more distal locations. In some instances, penetration of radiation to locations far from a device 12 is not desired. For example, in treating cancers such as bladder cancer, where the neoplastic tissue is generally located on the bladder surface, deep penetration is unnecessary and to be avoided. [0045] An inflation fluid may also be a radiation absorbing fluid. For example, an inflation fluid may be an X-ray contrast agent as used in angiography, such as a Barium salt (e.g., barium sulfate), water, saline or other such fluid. A radiation- absorbing inflation fluid, which will surround a radiation source placed within delivery shaft 28, serves to moderate and control the delivery of radiation from the radiation source to surrounding tissue. Such moderation and control that is obtained with a radiation-absorbing inflation fluid may aid in avoiding the delivery of an excessive amount of radiation to some portions of the surrounding tissue. [0046] Thus, in the absence of such a radiation-absorbing inflation fluid, it is possible in some instances that a radiation source sufficient to provide an effective dose at distances removed from a device 12, would expose tissue that is directly adjacent the wall of the outer balloon 14 or sheath 50 to an excessive radiation dose. Such excessive exposure to such tissue near to the device 12 may result in necrosis of healthy tissue necrosis.
[0047] Alternatively, an inflation fluid may contain radioactive elements, either as a liquid or slurry, so that the inner balloon 16 is filled with a source of radiation, providing a fairly uniform source of radiation that is distributed over the volume of the inner balloon 16. In such embodiments, an inflation fluid thus itself serves as a radiation source, thereby providing well-controlled amounts of radiation to surrounding tissue while minimizing irregularities in the dosages delivered to particular locations.
[0048] In embodiments of the invention in which an inflation fluid includes a radiation source, a delivery shaft 28 may contain a radiation absorptive material, so that, for example, less volume of radioactive material is required than if the entire volume of a device 12 were filled with radioactive material. Such a configuration may be advantageous where a profile exhibiting higher intensity at a tissue surface with lesser penetration is desired. Moreover, the outer balloon 14 need not be spherical, yet a uniform profile of radiation delivery is obtainable. Experiments reported in Williams U.S. Pat. No. 5,918,813 are described as showing that a steeper radial absorbed source gradient can be obtained using a radiation attenuation fluid in an inner chamber of a similar radiation deliver device than otherwise obtains with a device having only a single distensible chamber (as described in Williams U.S. Pat. No. 5,429,582).

Claims

WHAT IS CLAIMED IS
1. A device for treating tissue adjacent a body cavity, comprising: an inner balloon assembly including an inflation conduit configured to allow passage of a fluid and an inner balloon comprising a distensible inner balloon wall defining an internal lumen, said inner balloon being operatively connected to said inflation conduit so as to allow for passage of said fluid through said inflation conduit and into said internal lumen effective to inflate said inner balloon with said fluid; and a sheath assembly comprising a vacuum conduit and a fluid-permeable sheath wall configured to enclose said inner balloon assembly, effective to define an intermediate space between said inner balloon assembly and said sheath assembly, said sheath assembly being operatively connected to said vacuum conduit effective to provide vacuum to said intermediate space.
2. The device for treating tissue adjacent a body cavity of claim 1 , wherein said fluid-permeable sheath wall comprises a hole therethrough.
3. The device for treating tissue adjacent a body cavity of claim 1 , wherein said fluid-permeable sheath wall comprises a fluid-permeable material.
4. The device for treating tissue adjacent a body cavity of claim 3, wherein said fluid-permeable material comprises a woven material.
5. The device for treating tissue adjacent a body cavity of claim 1 , wherein said sheath wall includes separation elements configured to maintain a separation between said sheath wall and said inner balloon wall.
6. The device for treating tissue adjacent a body cavity of claim 1 , wherein said inner balloon wall includes separation elements configured to maintain a separation between said sheath wall and said inner balloon wall.
7. The device for treating tissue adjacent a body cavity of claim 1 , wherein said sheath wall comprises a flexible material.
8. The device for treating tissue adjacent a body cavity of claim 7, wherein said sheath wall comprises an elastic flexible material.
9. The device for treating tissue adjacent a body cavity of claim 8, wherein said sheath wall comprises an inelastic flexible material.
10. The device for treating tissue adjacent a body cavity of claim 1 , wherein said sheath wall comprises a polymer.
11. The device for treating tissue adjacent a body cavity of claim 1 , wherein said sheath wall comprises a biocompatible polymer.
12. The device for treating tissue adjacent a body cavity of claim 1 , wherein said sheath wall comprises a radiation-resistant polymer.
13. The device for treating tissue adjacent a body cavity of claim 10, wherein said polymer is selected from the group of polymers consisting of a polyolefin, polyethylene, polypropylene, polyurethane, polyester, polyvinylchloride, polystyrene, nylon, latex rubber, silicon rubber, a thermoplastic polymer, C-Flex®, an inonomer, Surlyn®, Kraton™ and SILASTIC™.
14. The device for treating tissue adjacent a body cavity of claim 1 , wherein said internal lumen is configured to enclose a treatment material.
15. The device for treating tissue adjacent a body cavity of claim 14, wherein said treatment material is selected from the group consisting of radioactive material, chemotherapeutic agents, and materials having a temperature greater than about 37 °C.
16. The device for treating tissue adjacent a body cavity of claim 1 , wherein said sheath assembly comprises an outer balloon assembly and said sheath wall comprises an outer balloon wall.
17. The device for treating tissue adjacent a body cavity of claim 16, wherein said outer balloon wall comprises a polymer.
18. The device for treating tissue adjacent a body cavity of claim 17, wherein said polymer is selected from the group of polymers consisting of a polyolefin, polyethylene, polypropylene, polyurethane, polyester, polyvinylchloride, polystyrene, nylon, latex rubber, silicon rubber, a thermoplastic polymer, C-Flex®, an inonomer, Surlyn®, Kraton™ and SILASTIC™.
19. The device for treating tissue adjacent a body cavity of claim 16, wherein said outer balloon wall is configured to enclose a treatment material.
20. The device for treating tissue adjacent a body cavity of claim 19, wherein said treatment material is selected from the group consisting of radioactive material, chemotherapeutic agents, and materials having a temperature greater than about 37 °C.
21. A system for treating tissue adjacent a body cavity, comprising: an inner balloon assembly including an inflation conduit configured to allow passage of a fluid and an inner balloon comprising a distensible inner balloon wall defining an internal lumen, said inner balloon being operatively connected to said inflation conduit so as to allow for passage of said fluid through said inflation conduit and into said internal lumen effective to inflate said inner balloon with said fluid; and a sheath assembly comprising a vacuum conduit and a fluid-permeable sheath wall configured to enclose said inner balloon assembly, effective to define an intermediate space between said inner balloon assembly and said sheath assembly, said sheath assembly being operatively connected to said vacuum conduit effective to provide vacuum to said intermediate space; and a vacuum source operatively configured to operatively connect with said vacuum conduit.
22. A system for treating tissue adjacent a body cavity, comprising: a means for contacting tissue adjacent a body cavity with a sheath, said sheath having a fluid-permeable wall, with an inner and an outer surface, said sheath being disposed outside of a distensible balloon, said balloon having an inner balloon lumen and containing a treatment material, said inner balloon lumen being operatively connected to an inflation conduit; and a means for applying a vacuum to said inner surface of said permeable wall of said balloon effective to enhance said contact between said fluid-permeable wall and said tissue.
23. The system for treating tissue adjacent a body cavity of claim 22, further comprising: a means for delivering inflation fluid to said inner balloon lumen via said inflation conduit effective to inflate said distensible balloon.
24. A system for treating tissue adjacent a body cavity, comprising:
a means for contacting tissue adjacent a body cavity with a balloon assembly, said balloon assembly having a fluid-permeable wall with an inner balloon wall surface and an outer balloon wall surface, said balloon assembly being disposed outside of a distensible inner balloon assembly, said inner balloon assembly having an inner balloon lumen and containing a treatment material, said inner balloon lumen being operatively connected to an inflation conduit; and a means for applying a vacuum to said inner balloon wall surface of said permeable wall of said balloon effective to enhance said contact between said fluid-permeable wall and said tissue.
25. The system of claim 24, further comprising: a means for delivering inflation fluid to said inner balloon lumen via said inflation conduit effective to inflate said distensible inner balloon assembly.
26. The system of claim 24, wherein said inner balloon assembly comprises an inflatable treatment delivery device.
27. The system of claim 26, wherein said inflatable treatment assembly comprises a device selected from a MammoSite® RTS, a GliaSite® RTS, and a device similar to a MammoSite® RTS.
28. The system of claim 26, further comprising replacing said treatment material.
29. A system for treating tissue adjacent a body cavity containing a treatment assembly, comprising: a means for applying a vacuum to said body cavity effective to draw said tissue adjacent the body cavity towards said treatment assembly.
30. The system of claim 29, wherein applying vacuum to said body cavity comprises applying vacuum to said body cavity via a vacuum conduit operatively attached to an enclosure device at least partly enclosing said treatment assembly.
31. A device for enhancing treatment of tissue adjacent a body cavity delivered by a treatment assembly configured for delivering a treatment to tissue adjacent a body cavity, comprising: enclosure device configured to at least partly enclose a treatment assembly for delivering a treatment to body tissue adjacent a body cavity; a vacuum conduit; and a vacuum port operatively connected to said vacuum conduit configured to provide suction adjacent said treatment assembly when said enclosure device is disposed to at least partly enclose said treatment assembly.
32. The device for enhancing treatment of tissue adjacent a body cavity delivered by a treatment assembly configured for delivering a treatment to tissue adjacent a body cavity of claim 31 , wherein said treatment assembly comprises an inflatable treatment delivery device.
33. The device for enhancing treatment of tissue adjacent a body cavity of claim 32, further comprising an enclosure assembly configured to at least partially enclose an inflatable treatment delivery device.
34. The device of claim 33, wherein said enclosure assembly comprises a fluid permeable surface.
35. The device of claim 34, wherein said enclosure assembly comprises a sheath.
36. The device of claim 34, wherein said enclosure assembly comprises a balloon.
37. The device of claim 34, wherein said inflatable treatment delivery device comprises a treatment delivery element configured to enclose a treatment material.
38. The device of claim 37, wherein said treatment material comprises a material selected from radioactive material, chemotherapeutic agents, and thermal treatment materials.
PCT/US2003/033775 2002-11-06 2003-10-28 Vaccum device for treating tissus adjacent a body cavity WO2004043531A2 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
JP2004551571A JP4563180B2 (en) 2002-11-06 2003-10-28 Vacuum instrument for treatment of tissue near the body cavity
EP03774946A EP1558324B1 (en) 2002-11-06 2003-10-28 Vaccum device for treating tissus adjacent a body cavity
DK03774946.2T DK1558324T3 (en) 2002-11-06 2003-10-28 Vacuum device for treating tissues near a body cavity
AT03774946T ATE511874T1 (en) 2002-11-06 2003-10-28 VACUUM DEVICE FOR TREATING TISSUE NEXT TO A BODY CAVITY
AU2003283014A AU2003283014A1 (en) 2002-11-06 2003-10-28 Vaccum device for treating tissus adjacent a body cavity
CA2504965A CA2504965C (en) 2002-11-06 2003-10-28 Vacuum device and method for treating tissue adjacent a body cavity

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/290,002 2002-11-06
US10/290,002 US6923754B2 (en) 2002-11-06 2002-11-06 Vacuum device and method for treating tissue adjacent a body cavity

Publications (2)

Publication Number Publication Date
WO2004043531A2 true WO2004043531A2 (en) 2004-05-27
WO2004043531A3 WO2004043531A3 (en) 2004-08-12

Family

ID=32176127

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2003/033775 WO2004043531A2 (en) 2002-11-06 2003-10-28 Vaccum device for treating tissus adjacent a body cavity

Country Status (10)

Country Link
US (7) US6923754B2 (en)
EP (2) EP1558324B1 (en)
JP (1) JP4563180B2 (en)
AT (1) ATE511874T1 (en)
AU (1) AU2003283014A1 (en)
CA (1) CA2504965C (en)
DK (1) DK1558324T3 (en)
ES (1) ES2365331T3 (en)
PT (1) PT1558324E (en)
WO (1) WO2004043531A2 (en)

Cited By (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005007229A2 (en) * 2003-07-16 2005-01-27 Scimed Life Systems, Inc. Temporary tissue spacer and pretreatment balloon
EP1568397A1 (en) * 2004-02-25 2005-08-31 Acrostak Corp. Balloon for brachytherapy and application of the balloon
EP1682213A2 (en) * 2003-10-10 2006-07-26 Xoft Microtube, Inc. Applicator for radiation treatment of a cavity
WO2007097956A2 (en) * 2006-02-17 2007-08-30 Senorx, Inc. Temporary catheter for biopsy site tissue fixation
WO2007061655A3 (en) * 2005-11-18 2007-11-15 Senorx Inc Tissue irradiation with shielding
WO2008008089A3 (en) * 2006-07-11 2008-03-06 Senorx Inc Asymmetrical irradiation of a body cavity
WO2008045812A1 (en) * 2006-10-08 2008-04-17 Cianna Medical, Inc. Expandable brachytherapy apparatus
JP2008526408A (en) * 2005-01-12 2008-07-24 アクロシュターク コーポレイション Indwelling treatment apparatus and treatment method for treatment of ablation cavity wall
US7517310B2 (en) 2005-11-18 2009-04-14 Senorx, Inc. Methods for tissue irradiation with shielding
US7942802B2 (en) 2002-11-06 2011-05-17 Senorx, Inc. Vacuum device and method for treating tissue adjacent a body cavity
US7981051B2 (en) 2005-08-05 2011-07-19 Senorx, Inc. Biopsy device with fluid delivery to tissue specimens
US8123698B2 (en) 2002-10-07 2012-02-28 Suros Surgical Systems, Inc. System and method for minimally invasive disease therapy
US8172770B2 (en) 2005-09-28 2012-05-08 Suros Surgical Systems, Inc. System and method for minimally invasive disease therapy
CN101045175B (en) * 2006-03-29 2012-07-04 微创医疗器械(上海)有限公司 Double-layered balloon catheter
US8740873B2 (en) 2007-03-15 2014-06-03 Hologic, Inc. Soft body catheter with low friction lumen
US8758214B2 (en) 2007-03-12 2014-06-24 Hologic, Inc. Radiation catheter with multilayered balloon
US8915864B2 (en) 2005-08-05 2014-12-23 Senorx, Inc. Biopsy device with fluid delivery to tissue specimens
US8932251B2 (en) 2011-03-10 2015-01-13 Western New England University Biopsy spacer device and method of operation
CN104436421A (en) * 2014-11-28 2015-03-25 刘宗军 Medicine injectable balloon
US9623260B2 (en) 2004-11-05 2017-04-18 Theragenics Corporation Expandable brachytherapy device
US9638770B2 (en) 2004-05-21 2017-05-02 Devicor Medical Products, Inc. MRI biopsy apparatus incorporating an imageable penetrating portion
US9795365B2 (en) 2004-05-21 2017-10-24 Devicor Medical Products, Inc. MRI biopsy apparatus incorporating a sleeve and multi-function obturator
US10022557B2 (en) 2010-09-30 2018-07-17 Hologic, Inc. Using a guided member to facilitate brachytherapy device swap
US10201688B2 (en) 2011-03-10 2019-02-12 Western New England University Biopsy spacer device and method of operation
US10207126B2 (en) 2009-05-11 2019-02-19 Cytyc Corporation Lumen visualization and identification system for multi-lumen balloon catheter
US10342992B2 (en) 2011-01-06 2019-07-09 Hologic, Inc. Orienting a brachytherapy applicator

Families Citing this family (130)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8092480B2 (en) * 2000-04-07 2012-01-10 Kyphon Sarl Platform cannula for guiding the expansion of expandable bodies and method of use
US7815649B2 (en) * 2000-04-07 2010-10-19 Kyphon SÀRL Insertion devices and method of use
US8845672B2 (en) * 2002-05-09 2014-09-30 Reshape Medical, Inc. Balloon system and methods for treating obesity
AU2003274960C1 (en) * 2002-09-10 2010-04-01 Cianna Medical, Inc. Brachytherapy apparatus
US20120289859A9 (en) * 2003-08-27 2012-11-15 Nicoson Zachary R System and method for minimally invasive disease therapy
CA2536394A1 (en) * 2003-09-03 2005-07-28 Rubicor Medical, Inc. Short term post surgical cavity treatment devices and methods
US7783006B2 (en) * 2003-10-10 2010-08-24 Xoft, Inc. Radiation treatment using x-ray source
US7127033B2 (en) 2004-02-28 2006-10-24 Xoft, Inc. Miniature x-ray tube cooling system
DE102004013012B3 (en) * 2004-03-16 2005-06-16 Universitätsklinikum Schleswig-Holstein Balloon catheter for minimally invasive heart surgery has outer suction membrane with gas permeable zone
US20050240073A1 (en) * 2004-04-26 2005-10-27 Apffelstaedt Justus P Devices and methods to conform and treat body cavities
US8932233B2 (en) 2004-05-21 2015-01-13 Devicor Medical Products, Inc. MRI biopsy device
US20060079727A1 (en) * 2004-09-03 2006-04-13 Rubicor Medical, Inc. Short term post surgical cavity treatment devices and methods
US7534202B2 (en) * 2004-10-04 2009-05-19 Board Of Regents, The University Of Texas System System and method for high dose rate radiation intracavitary brachytherapy
US8080057B2 (en) * 2005-08-09 2011-12-20 Steven J. Kronowitz Methods and devices for breast reconstruction
US20080200834A1 (en) * 2005-09-28 2008-08-21 Mark Joseph L Introducer device for improved imaging
US20070100368A1 (en) * 2005-10-31 2007-05-03 Quijano Rodolfo C Intragastric space filler
WO2007053823A2 (en) 2005-10-31 2007-05-10 Biolucent, Inc. Brachytherapy apparatus and methods of using same
WO2007059397A1 (en) 2005-11-10 2007-05-24 Biolucent, Inc. Helical brachytherapy apparatus and methods of using same
US7862496B2 (en) * 2005-11-10 2011-01-04 Cianna Medical, Inc. Brachytherapy apparatus and methods for using them
US20070119461A1 (en) * 2005-11-18 2007-05-31 Brian Biancucci Article isolation device and methods
US8273006B2 (en) * 2005-11-18 2012-09-25 Senorx, Inc. Tissue irradiation
US20070270627A1 (en) 2005-12-16 2007-11-22 North American Scientific Brachytherapy apparatus for asymmetrical body cavities
WO2007075545A2 (en) * 2005-12-16 2007-07-05 Xoft, Inc. Active drainage system for use in defined natural or surgically created body cavities or lumina
US8137256B2 (en) 2005-12-16 2012-03-20 Portola Medical, Inc. Brachytherapy apparatus
US20070173680A1 (en) * 2005-12-29 2007-07-26 Boston Scientific Scimed, Inc Apparatus and method for performing therapeutic tissue ablation and brachytherapy
WO2007106817A2 (en) * 2006-03-14 2007-09-20 Niyazi Beyhan Methods and apparatus for imaging and treating hollow body cavities
US7862497B2 (en) 2006-04-21 2011-01-04 Portola Medical, Inc. Brachytherapy device having seed tubes with individually-settable tissue spacings
US8486127B2 (en) * 2006-05-24 2013-07-16 Kambiz Dowlatshahi High temperature thermal therapy of breast cancer
US20140025056A1 (en) * 2006-05-24 2014-01-23 Kambiz Dowlatshahi Image-guided removal and thermal therapy of breast cancer
US9072893B2 (en) 2006-06-02 2015-07-07 Cianna Medical, Inc. Expandable brachytherapy apparatus and methods for using them
US7727137B2 (en) * 2006-10-13 2010-06-01 Xoft, Inc. Balloon brachytherapy applicator and method
US8012086B2 (en) * 2006-10-19 2011-09-06 Ethicon Endo-Surgery, Inc. Sterile transcolonic access device
US7357770B1 (en) 2006-11-03 2008-04-15 North American Scientific, Inc. Expandable brachytherapy device with constant radiation source spacing
US20080146861A1 (en) * 2006-12-18 2008-06-19 Goshen Health System, Inc. Brachytherapy Shielding System
US7655004B2 (en) 2007-02-15 2010-02-02 Ethicon Endo-Surgery, Inc. Electroporation ablation apparatus, system, and method
US20080228023A1 (en) * 2007-03-15 2008-09-18 Senorx, Inc. Soft body catheter with low friction lumen
US8226602B2 (en) * 2007-03-30 2012-07-24 Reshape Medical, Inc. Intragastric balloon system and therapeutic processes and products
US20090306646A1 (en) * 2007-05-14 2009-12-10 Bsd Medical Corporation Apparatus and method for injection enhancement of selective heating of a deposit in tissues in a body
US8423152B2 (en) * 2007-05-14 2013-04-16 Bsd Medical Corporation Apparatus and method for selectively heating a deposit in fatty tissue in a body
US9387036B2 (en) * 2007-05-14 2016-07-12 Pyrexar Medical Inc. Apparatus and method for selectively heating a deposit in fatty tissue in a body
US20080300571A1 (en) * 2007-05-30 2008-12-04 Lepivert Patrick Process and device for selectively treating interstitial tissue
US8114005B2 (en) * 2007-06-04 2012-02-14 Xoft, Inc. Method for modifying skin distance from a brachytherapy balloon applicator
US8142469B2 (en) * 2007-06-25 2012-03-27 Reshape Medical, Inc. Gastric space filler device, delivery system, and related methods
US7771340B2 (en) * 2007-07-28 2010-08-10 Xoft, Inc. Method and apparatus for modifying distance from a brachytherapy radiation source to sensitive anatomical structures
US8202229B2 (en) 2007-10-01 2012-06-19 Suros Surgical Systems, Inc. Surgical device
US8808200B2 (en) 2007-10-01 2014-08-19 Suros Surgical Systems, Inc. Surgical device and method of using same
US8409070B2 (en) * 2007-10-26 2013-04-02 Xoft, Inc. Brachytherapy apparatus and method for use with minimally invasive surgeries of the lung
US20090143728A1 (en) * 2007-11-30 2009-06-04 Numed, Inc. Balloon catheter with safety feature
WO2009079170A2 (en) 2007-12-16 2009-06-25 Cianna Medical, Inc. Expandable brachytherapy apparatus and methods for using them
US20090188098A1 (en) 2008-01-24 2009-07-30 Senorx, Inc. Multimen brachytherapy balloon catheter
US8550972B2 (en) 2008-02-29 2013-10-08 Varian Medical Systems, Inc. Systems and methods for delivering radiation therapy
US20100010287A1 (en) * 2008-07-09 2010-01-14 Senorx, Inc. Brachytherapy device with one or more toroidal balloons
US8888792B2 (en) 2008-07-14 2014-11-18 Ethicon Endo-Surgery, Inc. Tissue apposition clip application devices and methods
US8636635B2 (en) 2008-08-18 2014-01-28 Cianna Medical, Inc. Brachytherapy apparatus, systems, and methods for using them
US8500618B2 (en) * 2008-09-11 2013-08-06 Radiadyne, Llc Dual gynecological balloon packing system
US20100094074A1 (en) * 2008-10-10 2010-04-15 Hologic Inc. Brachytherapy apparatus and methods employing expandable medical devices comprising fixation elements
US8157834B2 (en) 2008-11-25 2012-04-17 Ethicon Endo-Surgery, Inc. Rotational coupling device for surgical instrument with flexible actuators
DE102008060162A1 (en) * 2008-12-02 2010-06-10 Carl Zeiss Surgical Gmbh Balloon catheter and applicator with balloon catheter
US8361066B2 (en) 2009-01-12 2013-01-29 Ethicon Endo-Surgery, Inc. Electrical ablation devices
US9579524B2 (en) 2009-02-11 2017-02-28 Hologic, Inc. Flexible multi-lumen brachytherapy device
US9248311B2 (en) 2009-02-11 2016-02-02 Hologic, Inc. System and method for modifying a flexibility of a brachythereapy catheter
EP2405814B1 (en) * 2009-03-09 2016-11-16 Flip Technologies Limited A device for protecting a catheter
US9174031B2 (en) * 2009-03-13 2015-11-03 Reshape Medical, Inc. Device and method for deflation and removal of implantable and inflatable devices
JP5670424B2 (en) * 2009-04-03 2015-02-18 リシェイプ メディカル, インコーポレイテッド Improved gastric space filling and manufacturing method including in vitro testing
US8663210B2 (en) 2009-05-13 2014-03-04 Novian Health, Inc. Methods and apparatus for performing interstitial laser therapy and interstitial brachytherapy
US8033995B2 (en) * 2009-06-05 2011-10-11 Ethicon Endo-Surgery, Inc. Inflatable retractor with insufflation and method
US20100331878A1 (en) * 2009-06-25 2010-12-30 Carl Zeiss Surgical Gmbh Method and device for removing a balloon from a body cavity
WO2011011629A2 (en) 2009-07-22 2011-01-27 Reshape Medical, Inc. Retrieval mechanisms for implantable medical devices
US9604038B2 (en) 2009-07-23 2017-03-28 Reshape Medical, Inc. Inflation and deflation mechanisms for inflatable medical devices
WO2011011743A2 (en) 2009-07-23 2011-01-27 Reshape Medical, Inc. Deflation and removal of implantable medical devices
EP2480279A4 (en) 2009-09-24 2017-11-15 Reshape Medical, Inc. Normalization and stabilization of balloon surfaces for deflation
US20110098704A1 (en) 2009-10-28 2011-04-28 Ethicon Endo-Surgery, Inc. Electrical ablation devices
US9028483B2 (en) 2009-12-18 2015-05-12 Ethicon Endo-Surgery, Inc. Surgical instrument comprising an electrode
US10016620B2 (en) 2010-02-04 2018-07-10 Procept Biorobotics Incorporation Tissue sampling and cancer treatment apparatus
US9622896B2 (en) 2010-02-08 2017-04-18 Reshape Medical, Inc. Enhanced aspiration processes and mechanisms for instragastric devices
EP2533846B1 (en) 2010-02-08 2018-08-22 ReShape Medical LLC Materials and methods for improved intragastric balloon devices
WO2011100586A1 (en) 2010-02-12 2011-08-18 Vivaray, Inc. Brachytherapy applicator
WO2011106637A1 (en) 2010-02-25 2011-09-01 Reshape Medical, Inc. Improved and enhanced explant processes and mechanisms for intragastric devices
US8814775B2 (en) 2010-03-18 2014-08-26 Cianna Medical, Inc. Expandable brachytherapy apparatus and methods for using them
WO2011127205A1 (en) 2010-04-06 2011-10-13 Reshape Medical , Inc. Inflation devices for intragastric devices with improved attachment and detachment and associated systems and methods
US9883919B2 (en) 2010-07-21 2018-02-06 Cianna Medical, Inc. Brachytherapy apparatus, systems, and methods for using them
US9402980B2 (en) 2010-09-23 2016-08-02 Best Medical International, Inc. Rectal catheter for urological and other applications
US10589071B2 (en) 2010-09-23 2020-03-17 Best Medical International, Inc. Multiple function balloon catheter
US10744307B2 (en) 2010-09-23 2020-08-18 Best Medical International, Inc. Multi-purpose balloon catheter for intra cavity radiation delivery
US9067063B2 (en) 2010-11-03 2015-06-30 Cianna Medical, Inc. Expandable brachytherapy apparatus and methods for using them
US20120150107A1 (en) * 2010-12-14 2012-06-14 Boston Scientific Scimed, Inc. Balloon catheter shafts and methods of manufacturing
WO2012096787A1 (en) * 2010-12-30 2012-07-19 Surmodics, Inc. Double wall catheter for delivering therapeutic agent
US9498644B2 (en) 2011-01-03 2016-11-22 Best Medical International, Inc. Apparatus for brachytherapy
US9283402B2 (en) 2011-01-03 2016-03-15 Best Medical International, Inc. Apparatus and method for providing a double balloon breast brachytherapy device
US9233241B2 (en) 2011-02-28 2016-01-12 Ethicon Endo-Surgery, Inc. Electrical ablation devices and methods
US9254169B2 (en) 2011-02-28 2016-02-09 Ethicon Endo-Surgery, Inc. Electrical ablation devices and methods
US8348890B2 (en) * 2011-03-01 2013-01-08 Sanovas, Inc. Nested balloon catheter for localized drug delivery
US10898693B2 (en) 2011-03-01 2021-01-26 Sanovas Intellectual Property, Llc Nasal delivery of agents with nested balloon catheter
US9049987B2 (en) 2011-03-17 2015-06-09 Ethicon Endo-Surgery, Inc. Hand held surgical device for manipulating an internal magnet assembly within a patient
US9180281B2 (en) * 2011-04-08 2015-11-10 Sanovas, Inc. Adjustable balloon catheter for extravasated drug delivery
US20130090666A1 (en) * 2011-10-06 2013-04-11 Ethicon Endo-Surgery, Inc. Vacuum assisted tissue manipulation devices and surgical methods
US9173657B2 (en) 2011-12-15 2015-11-03 Ethicon Endo-Surgery, Inc. Devices and methods for endoluminal plication
US9113866B2 (en) 2011-12-15 2015-08-25 Ethicon Endo-Surgery, Inc. Devices and methods for endoluminal plication
US8992547B2 (en) 2012-03-21 2015-03-31 Ethicon Endo-Surgery, Inc. Methods and devices for creating tissue plications
US9427255B2 (en) 2012-05-14 2016-08-30 Ethicon Endo-Surgery, Inc. Apparatus for introducing a steerable camera assembly into a patient
US9078662B2 (en) 2012-07-03 2015-07-14 Ethicon Endo-Surgery, Inc. Endoscopic cap electrode and method for using the same
US9545290B2 (en) 2012-07-30 2017-01-17 Ethicon Endo-Surgery, Inc. Needle probe guide
US10314649B2 (en) 2012-08-02 2019-06-11 Ethicon Endo-Surgery, Inc. Flexible expandable electrode and method of intraluminal delivery of pulsed power
US9572623B2 (en) 2012-08-02 2017-02-21 Ethicon Endo-Surgery, Inc. Reusable electrode and disposable sheath
US9277957B2 (en) 2012-08-15 2016-03-08 Ethicon Endo-Surgery, Inc. Electrosurgical devices and methods
US10098527B2 (en) 2013-02-27 2018-10-16 Ethidcon Endo-Surgery, Inc. System for performing a minimally invasive surgical procedure
WO2015179631A1 (en) * 2014-05-21 2015-11-26 The Regents Of The University Of Michigan Fenestrated decoupling system for internal selective attachment to soft tissue organs
EP3145418B1 (en) * 2014-05-21 2019-04-03 The Regents of The University of Michigan Fenestrated decoupling system for internal selective attachment to soft tissue organs
ES2886204T3 (en) * 2014-06-24 2021-12-16 Procept Biorobotics Corp Cancer Treatment and Tissue Sampling Apparatus
US10117738B2 (en) 2015-01-23 2018-11-06 The Regents Of The University Of Michigan Atraumatic tip geometry for indwelling devices
EP3685782B1 (en) * 2015-04-29 2021-11-03 Innoblative Designs, Inc. Cavitary tissue ablation
WO2017041052A1 (en) 2015-09-03 2017-03-09 Neptune Medical Device for endoscopic advancement through the small intestine
EP3367945B1 (en) 2015-10-29 2020-02-26 Innoblative Designs, Inc. Screen sphere tissue ablation devices
JP6630836B2 (en) 2016-02-02 2020-01-15 イノブレイティブ デザインズ, インコーポレイテッド Cavity tissue ablation system
WO2017151431A1 (en) 2016-03-01 2017-09-08 Innoblative Designs, Inc. Resecting and coagulating tissue
US20160206296A1 (en) * 2016-03-25 2016-07-21 Hamid Ehsani-Nia Biopsy Syringe Device
WO2018035452A1 (en) 2016-08-18 2018-02-22 Neptune Medical Device and method for enhanced visualization of the small intestine
JP2019536509A (en) 2016-10-17 2019-12-19 イノブレイティブ デザインズ, インコーポレイテッド Treatment device and method
WO2018144090A2 (en) 2016-11-08 2018-08-09 Innoblative Designs, Inc. Electrosurgical tissue and vessel sealing device
JP2020530785A (en) 2017-07-26 2020-10-29 イノブレイティブ デザインズ, インコーポレイテッド Minimally invasive joint motion assembly with ablation capability
EP3823711A4 (en) 2018-07-19 2022-05-18 Neptune Medical Inc. Dynamically rigidizing composite medical structures
JP7177857B2 (en) * 2019-01-10 2022-11-24 オリンパス株式会社 phototherapy device
US11793392B2 (en) 2019-04-17 2023-10-24 Neptune Medical Inc. External working channels
US11383093B1 (en) 2019-12-06 2022-07-12 Hoseon LEE Radiation release capsule
CN110975175B (en) * 2020-01-06 2021-12-07 温州市中心医院 Radiation therapy protector in gynaecology's tumour intracavity
AU2021245989A1 (en) 2020-03-30 2022-10-27 Neptune Medical Inc. Layered walls for rigidizing devices
CN111569277B (en) * 2020-05-13 2022-02-18 戴建荣 Radiotherapy target region separator
EP4085855A1 (en) * 2021-05-04 2022-11-09 Hemosquid Hemostatic device
WO2022233895A1 (en) * 2021-05-04 2022-11-10 Hemosquid Hemostatic device
WO2023081072A1 (en) * 2021-11-05 2023-05-11 Cook Medical Technologies Llc Uterine tamponade device

Family Cites Families (156)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3324847A (en) * 1964-06-01 1967-06-13 Elias G Zoumboulis Radioactive catheter
US3872856A (en) * 1971-06-09 1975-03-25 Ralph S Clayton Apparatus for treating the walls and floor of the pelvic cavity with radiation
US3975350A (en) 1972-08-02 1976-08-17 Princeton Polymer Laboratories, Incorporated Hydrophilic or hydrogel carrier systems such as coatings, body implants and other articles
US4119094A (en) 1977-08-08 1978-10-10 Biosearch Medical Products Inc. Coated substrate having a low coefficient of friction hydrophilic coating and a method of making the same
US4454106A (en) 1982-06-07 1984-06-12 Gansow Otto A Use of metal chelate conjugated monoclonal antibodies
US4571241A (en) 1983-12-16 1986-02-18 Christopher T Graham Urinary catheter with collapsible urethral tube
US4690677A (en) * 1985-09-25 1987-09-01 Daltex Medical Sciences, Inc. Urine collection system for females
US4763642A (en) 1986-04-07 1988-08-16 Horowitz Bruce S Intracavitational brachytherapy
JPS6446056U (en) 1987-09-17 1989-03-22
US4998917A (en) 1988-05-26 1991-03-12 Advanced Cardiovascular Systems, Inc. High torque steerable dilatation catheter
US5227969A (en) 1988-08-01 1993-07-13 W. L. Systems, Inc. Manipulable three-dimensional projection imaging method
US4998930A (en) * 1988-08-03 1991-03-12 Phototherapeutic Systems Intracavity laser phototherapy method
US4929470A (en) 1989-02-24 1990-05-29 James River Corporation Method of making decorative cast-coated paper
US5312356A (en) 1989-05-22 1994-05-17 Target Therapeutics Catheter with low-friction distal segment
US5535817A (en) 1989-07-28 1996-07-16 Uop Sorption cooling process and apparatus
US5059166A (en) 1989-12-11 1991-10-22 Medical Innovative Technologies R & D Limited Partnership Intra-arterial stent with the capability to inhibit intimal hyperplasia
US5439446A (en) * 1994-06-30 1995-08-08 Boston Scientific Corporation Stent and therapeutic delivery system
DE3941705C2 (en) * 1989-12-18 1994-10-13 Gsf Forschungszentrum Umwelt Device for the isotropic irradiation of cavities of spherical shape
US5199939B1 (en) 1990-02-23 1998-08-18 Michael D Dake Radioactive catheter
US5422926A (en) 1990-09-05 1995-06-06 Photoelectron Corporation X-ray source with shaped radiation pattern
US5167622A (en) * 1990-12-07 1992-12-01 Smiths Industries Medical Systems, Inc. Triple conduit suction catheter
US5429582A (en) * 1991-06-14 1995-07-04 Williams; Jeffery A. Tumor treatment
US5931774A (en) 1991-06-14 1999-08-03 Proxima Therapeutics, Inc. Inflatable devices for tumor treatment
AU649845B2 (en) 1991-06-24 1994-06-02 Sumitomo Electric Industries, Ltd. Method for producing glass preform for optical fiber
US5766151A (en) * 1991-07-16 1998-06-16 Heartport, Inc. Endovascular system for arresting the heart
US5302168A (en) 1991-09-05 1994-04-12 Hess Robert L Method and apparatus for restenosis treatment
DE59108725D1 (en) * 1991-10-11 1997-07-03 Erbe Elektromedizin Instrument for high frequency surgery for cutting or coagulating
US5431662A (en) 1992-02-12 1995-07-11 United States Surgical Corporation Manipulator apparatus
US5259847A (en) 1992-06-25 1993-11-09 Montefiore Hospital And Medical Center Catheter to maintain minimally invasive access for exchanging internal biliary stents
US6623516B2 (en) * 1992-08-13 2003-09-23 Mark A. Saab Method for changing the temperature of a selected body region
US5342305A (en) 1992-08-13 1994-08-30 Cordis Corporation Variable distention angioplasty balloon assembly
US5417687A (en) 1993-04-30 1995-05-23 Medical Scientific, Inc. Bipolar electrosurgical trocar
US5381504A (en) 1993-11-15 1995-01-10 Minnesota Mining And Manufacturing Company Optical fiber element having a permanent protective coating with a Shore D hardness value of 65 or more
US5503613A (en) 1994-01-21 1996-04-02 The Trustees Of Columbia University In The City Of New York Apparatus and method to reduce restenosis after arterial intervention
US5538510A (en) 1994-01-31 1996-07-23 Cordis Corporation Catheter having coextruded tubing
US5670558A (en) 1994-07-07 1997-09-23 Terumo Kabushiki Kaisha Medical instruments that exhibit surface lubricity when wetted
CA2194759C (en) * 1994-07-12 1999-09-14 Donald O. Smith X-ray apparatus for applying a predetermined flux to an interior surface of a body cavity
US5566221A (en) 1994-07-12 1996-10-15 Photoelectron Corporation Apparatus for applying a predetermined x-radiation flux to an interior surface of a body cavity
US5899882A (en) * 1994-10-27 1999-05-04 Novoste Corporation Catheter apparatus for radiation treatment of a desired area in the vascular system of a patient
ES2181802T3 (en) 1994-11-23 2003-03-01 Micro Interventional Systems I BALLOON CATHETER WITH STRONG TORSION.
WO1996015819A1 (en) 1994-11-23 1996-05-30 Navarre Biomedical, Ltd. Flexible catheter
US5616114A (en) 1994-12-08 1997-04-01 Neocardia, Llc. Intravascular radiotherapy employing a liquid-suspended source
ATE297787T1 (en) 1994-12-27 2005-07-15 Olympus Optical Co MEDICAL DEVICE
US5653683A (en) 1995-02-28 1997-08-05 D'andrea; Mark A. Intracavitary catheter for use in therapeutic radiation procedures
AU693357B2 (en) 1995-04-28 1998-06-25 Target Therapeutics, Inc. High performance braided catheter
JPH11504829A (en) 1995-05-05 1999-05-11 アドバンスト・カーディオバスキュラー・システムズ・インコーポレイテッド In-pipe device with anti-friction surface
US6256529B1 (en) 1995-07-26 2001-07-03 Burdette Medical Systems, Inc. Virtual reality 3D visualization for surgical procedures
US5603991A (en) 1995-09-29 1997-02-18 Target Therapeutics, Inc. Method for coating catheter lumens
JP4020965B2 (en) 1995-10-06 2007-12-12 フォトエレクトロン コーポレイション Device for irradiating the inner surface of a body cavity with X-rays
US5840008A (en) * 1995-11-13 1998-11-24 Localmed, Inc. Radiation emitting sleeve catheter and methods
AU712539B2 (en) * 1996-01-08 1999-11-11 Biosense, Inc. Methods and apparatus for myocardial revascularization
DE69716038T2 (en) 1996-01-31 2003-08-14 Du Pont DILATATION BALLOON CATHETER WITH IMPROVED HOLE RESISTANCE
US5855546A (en) * 1996-02-29 1999-01-05 Sci-Med Life Systems Perfusion balloon and radioactive wire delivery system
US5916143A (en) 1996-04-30 1999-06-29 Apple; Marc G. Brachytherapy catheter system
US6235037B1 (en) 1996-05-24 2001-05-22 West-Walker Bennett Surgical apparatus
US5993972A (en) 1996-08-26 1999-11-30 Tyndale Plains-Hunter, Ltd. Hydrophilic and hydrophobic polyether polyurethanes and uses therefor
US5924973A (en) 1996-09-26 1999-07-20 The Trustees Of Columbia University In The City Of New York Method of treating a disease process in a luminal structure
IT1288728B1 (en) 1996-10-04 1998-09-24 Bridgestone Firestone Tech METALLIC HEEL FOR TIRES AND METHOD FOR ITS REALIZATION.
JP3810157B2 (en) * 1996-11-07 2006-08-16 オリンパス株式会社 Suction biopsy tool
US5935098A (en) * 1996-12-23 1999-08-10 Conceptus, Inc. Apparatus and method for accessing and manipulating the uterus
US5879282A (en) 1997-01-21 1999-03-09 Cordis A Johnson And Johnson Company Catheter having an expandable radioactive source
US5863285A (en) 1997-01-30 1999-01-26 Cordis Corporation Balloon catheter with radioactive means
US6458069B1 (en) 1998-02-19 2002-10-01 Endology, Inc. Multi layer radiation delivery balloon
US5782742A (en) 1997-01-31 1998-07-21 Cardiovascular Dynamics, Inc. Radiation delivery balloon
EP0860181B1 (en) 1997-02-21 2004-04-28 Medtronic Ave, Inc. X-ray device having a dilatation structure for delivering localized radiation to an interior of a body
US6770058B1 (en) 1997-03-11 2004-08-03 Interventional Therapies, Llc Treatment catheter insert
US6033357A (en) 1997-03-28 2000-03-07 Navius Corporation Intravascular radiation delivery device
US5868708A (en) * 1997-05-07 1999-02-09 Applied Medical Resources Corporation Balloon catheter apparatus and method
US5919473A (en) 1997-05-12 1999-07-06 Elkhoury; George F. Methods and devices for delivering opioid analgesics to wounds via a subdermal implant
US5918813A (en) 1997-06-17 1999-07-06 Rucker; David L. Rotating spray head
US6482142B1 (en) 1997-07-24 2002-11-19 Proxima Therapeutics, Inc. Asymmetric radiation dosing apparatus and method
US5913813A (en) 1997-07-24 1999-06-22 Proxima Therapeutics, Inc. Double-wall balloon catheter for treatment of proliferative tissue
AU738093B2 (en) * 1997-09-11 2001-09-06 Marc G. Apple Medical radiation treatment delivery apparatus
US6019922A (en) 1997-10-01 2000-02-01 Johnson & Johnson Mfg Sn Bhd Powder-free medical gloves
US6129670A (en) 1997-11-24 2000-10-10 Burdette Medical Systems Real time brachytherapy spatial registration and visualization system
EP1079730B1 (en) 1997-11-24 2007-01-03 Computerized Medical Systems, Inc. Real time brachytherapy spatial registration and visualization system
US5997462A (en) 1998-01-08 1999-12-07 Delft Instruments Intellectual Property B.V. Method and apparatus for treating a blood vessel lesion
CN1224430C (en) 1998-01-30 2005-10-26 钟渊化学工业株式会社 Balloon catheter, catheter shaft used for the catheter and method of production of balloon
US6036631A (en) * 1998-03-09 2000-03-14 Urologix, Inc. Device and method for intracavitary cancer treatment
US6905494B2 (en) * 1998-03-31 2005-06-14 Innercool Therapies, Inc. Method and device for performing cooling- or cryo-therapies for, e.g., angioplasty with reduced restenosis or pulmonary vein cell necrosis to inhibit atrial fibrillation employing tissue protection
US6086970A (en) 1998-04-28 2000-07-11 Scimed Life Systems, Inc. Lubricious surface extruded tubular members for medical devices
US6093142A (en) 1998-04-30 2000-07-25 Medtronic Inc. Device for in vivo radiation delivery and method for delivery
EP1096965B1 (en) 1998-07-16 2007-12-05 Mark Cohen Reinforced variable stiffness tubing
US7967855B2 (en) 1998-07-27 2011-06-28 Icon Interventional Systems, Inc. Coated medical device
US7276063B2 (en) * 1998-08-11 2007-10-02 Arthrocare Corporation Instrument for electrosurgical tissue treatment
US6413203B1 (en) * 1998-09-16 2002-07-02 Scimed Life Systems, Inc. Method and apparatus for positioning radioactive fluids within a body lumen
US6645483B2 (en) 1998-10-07 2003-11-11 Sherwood Services Ag Lubricious coating
US7141246B2 (en) 1998-10-07 2006-11-28 Sherwood Services Ag Lubricious coating
US6605030B2 (en) 1998-11-09 2003-08-12 The Trustees Of Columbia University In The City Of New York Apparatus and method for treating a disease process in a luminal structure
US6200257B1 (en) 1999-03-24 2001-03-13 Proxima Therapeutics, Inc. Catheter with permeable hydrogel membrane
US6319188B1 (en) * 1999-04-26 2001-11-20 Xoft Microtube, Inc. Vascular X-ray probe
US6464625B2 (en) 1999-06-23 2002-10-15 Robert A. Ganz Therapeutic method and apparatus for debilitating or killing microorganisms within the body
US6251060B1 (en) 1999-07-23 2001-06-26 Nucletron B.V. Apparatus and method for temporarily inserting a radioactive source in an animal body
US6575966B2 (en) 1999-08-23 2003-06-10 Cryocath Technologies Inc. Endovascular cryotreatment catheter
US6610013B1 (en) 1999-10-01 2003-08-26 Life Imaging Systems, Inc. 3D ultrasound-guided intraoperative prostate brachytherapy
JP2001110181A (en) 1999-10-13 2001-04-20 Oki Electric Ind Co Ltd Semiconductor memory
JP4445617B2 (en) * 1999-10-27 2010-04-07 オリンパス株式会社 Endoscopic treatment tool
US20030144570A1 (en) 1999-11-12 2003-07-31 Angiotech Pharmaceuticals, Inc. Compositions and methods for treating disease utilizing a combination of radioactive therapy and cell-cycle inhibitors
EP1235598A2 (en) 1999-11-12 2002-09-04 Angiotech Pharmaceuticals, Inc. Compositions of a combination of radioactive therapy and cell-cycle inhibitors
US7109505B1 (en) 2000-02-11 2006-09-19 Carl Zeiss Ag Shaped biocompatible radiation shield and method for making same
US6615070B2 (en) 2000-06-01 2003-09-02 Georgia Tech Research Corporation Automated planning volume contouring algorithm for adjuvant brachytherapy treatment planning in sarcoma
US6390968B1 (en) 2000-06-07 2002-05-21 Paxton Equities, Llc Cervical applicator for high dose radiation brachytherapy
JP2002017774A (en) * 2000-07-05 2002-01-22 Olympus Optical Co Ltd Microwave therapeutic device
WO2002009599A2 (en) 2000-07-31 2002-02-07 Boston Scientific Limited Expandable atherectomy burr
US6390967B1 (en) * 2000-09-14 2002-05-21 Xoft Microtube, Inc. Radiation for inhibiting hyperplasia after intravascular intervention
US6416492B1 (en) * 2000-09-28 2002-07-09 Scimed Life Systems, Inc. Radiation delivery system utilizing intravascular ultrasound
US6540655B1 (en) * 2000-11-10 2003-04-01 Scimed Life Systems, Inc. Miniature x-ray unit
US6554757B1 (en) * 2000-11-10 2003-04-29 Scimed Life Systems, Inc. Multi-source x-ray catheter
US6540720B1 (en) * 2000-11-10 2003-04-01 Scimed Life Systems, Inc. Miniature x-ray unit
US7179251B2 (en) 2001-01-17 2007-02-20 Boston Scientific Scimed, Inc. Therapeutic delivery balloon
US6527693B2 (en) * 2001-01-30 2003-03-04 Implant Sciences Corporation Methods and implants for providing radiation to a patient
US6723052B2 (en) 2001-06-07 2004-04-20 Stanley L. Mills Echogenic medical device
US6673006B2 (en) 2001-06-15 2004-01-06 Proxima Therapeutics, Inc. Tissue positioning apparatus and method for protecting tissue from radiotherapy
US6746392B2 (en) * 2001-06-20 2004-06-08 Medtronic Ave, Inc. Brachytherapy catheter with twisted lumens and methods of use
US6746465B2 (en) 2001-12-14 2004-06-08 The Regents Of The University Of California Catheter based balloon for therapy modification and positioning of tissue
DE60333566D1 (en) 2002-08-13 2010-09-09 Medtronic Inc MEDICAL DEVICE WITH IMPROVED LIABILITY BETWEEN A POLYMERIC TOUCH AND A SUBSTRATE
US6758069B2 (en) * 2002-08-30 2004-07-06 Acco Brands, Inc. Computer physical security devices
AU2003274960C1 (en) * 2002-09-10 2010-04-01 Cianna Medical, Inc. Brachytherapy apparatus
US8162855B2 (en) 2002-09-20 2012-04-24 Seven Dreamers Laboratories, Inc. Medical guide wire and process for production thereof
ES2280484T3 (en) 2002-09-27 2007-09-16 Nucletron B.V. DEVICE FOR THE TREATMENT BY RADIATION OF PROLIFERATIVE FABRIC THAT SURROUND A CAVITY IN AN ANIMAL BODY.
JP2004121553A (en) * 2002-10-02 2004-04-22 Terumo Corp Thermotherapeutic instrument
US6983754B1 (en) 2002-10-11 2006-01-10 Anderson Randy M Bag washing apparatus and method
US6923754B2 (en) * 2002-11-06 2005-08-02 Senorx, Inc. Vacuum device and method for treating tissue adjacent a body cavity
US7267649B2 (en) * 2003-01-24 2007-09-11 Proteus Biomedical, Inc. Method and system for remote hemodynamic monitoring
US7098463B2 (en) 2003-03-03 2006-08-29 Heuris Pharma, Llc Three-dimensional dosimeter for penetrating radiation and method of use
US7578780B2 (en) * 2003-06-18 2009-08-25 Xoft, Inc. Brachytherapy applicator for delivery and assessment of low-level ionizing radiation therapy and methods of use
US7322929B2 (en) * 2003-06-18 2008-01-29 Xoft, Inc. Method for radiation treatment
US7338430B2 (en) 2003-06-18 2008-03-04 Xoft, Inc. Gynecological brachytherapy applicator and system
US7513861B2 (en) 2003-06-18 2009-04-07 Xoft, Inc. Real time verification in radiation treatment
CA2536394A1 (en) 2003-09-03 2005-07-28 Rubicor Medical, Inc. Short term post surgical cavity treatment devices and methods
US7744587B2 (en) 2003-09-22 2010-06-29 Boston Scientific Scimed, Inc. Surface modified reinforcing member for medical device and method for making same
US20050080313A1 (en) 2003-10-10 2005-04-14 Stewart Daren L. Applicator for radiation treatment of a cavity
US7783006B2 (en) 2003-10-10 2010-08-24 Xoft, Inc. Radiation treatment using x-ray source
US7438875B2 (en) 2003-10-16 2008-10-21 Kimberly-Clark Worldwide, Inc. Method for reducing odor using metal-modified silica particles
WO2005065079A2 (en) 2003-11-10 2005-07-21 Angiotech International Ag Medical implants and fibrosis-inducing agents
US20050124843A1 (en) * 2003-12-09 2005-06-09 Washington University Method and apparatus for delivering targeted therapy to a patient
WO2005065761A2 (en) 2003-12-31 2005-07-21 C. R. Bard, Inc. Reinforced multi-lumen catheter
US20050240073A1 (en) 2004-04-26 2005-10-27 Apffelstaedt Justus P Devices and methods to conform and treat body cavities
GB2415907A (en) 2004-07-05 2006-01-11 Vishnu Shanker Shukla A radiotherapy device for treating cancers in viscous organs such as the bladder
US7850675B2 (en) 2004-07-20 2010-12-14 Boston Scientific Scimed, Inc. Reinforced venous access catheter
ATE442187T1 (en) 2004-07-20 2009-09-15 Nucletron Bv DEVICE FOR RADIATION TREATMENT OF PROLIFERATIVE TISSUE BOUNDARY TO A BODY CAVITY
US7534202B2 (en) * 2004-10-04 2009-05-19 Board Of Regents, The University Of Texas System System and method for high dose rate radiation intracavitary brachytherapy
US7662082B2 (en) 2004-11-05 2010-02-16 Theragenics Corporation Expandable brachytherapy device
EP1816945B1 (en) 2004-11-23 2019-08-21 PneumRx, Inc. Steerable device for accessing a target site
EP1922113A1 (en) 2005-08-11 2008-05-21 Navotek Medical Ltd. Medical treatment system and method using radioactivity based position sensor
US20070049786A1 (en) 2005-08-30 2007-03-01 Cytyc Corporation Safety-link brachytherapy catheter
US7862496B2 (en) 2005-11-10 2011-01-04 Cianna Medical, Inc. Brachytherapy apparatus and methods for using them
WO2007059397A1 (en) 2005-11-10 2007-05-24 Biolucent, Inc. Helical brachytherapy apparatus and methods of using same
US20070270627A1 (en) * 2005-12-16 2007-11-22 North American Scientific Brachytherapy apparatus for asymmetrical body cavities
US9072893B2 (en) 2006-06-02 2015-07-07 Cianna Medical, Inc. Expandable brachytherapy apparatus and methods for using them
JP2010500153A (en) 2006-08-14 2010-01-07 ノベリス・インコーポレーテッド Imaging apparatus, imaging system, and imaging method
US20080057298A1 (en) 2006-08-29 2008-03-06 Surmodics, Inc. Low friction particulate coatings
EP2380630B1 (en) 2006-10-08 2013-01-16 Cianna Medical, Inc. Expandable brachytherapy apparatus
US20080221479A1 (en) 2007-03-07 2008-09-11 Ritchie Paul G Integrated Imaging and Biopsy System with Integrated Utilities
US8740873B2 (en) 2007-03-15 2014-06-03 Hologic, Inc. Soft body catheter with low friction lumen
US20090188098A1 (en) 2008-01-24 2009-07-30 Senorx, Inc. Multimen brachytherapy balloon catheter

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
None

Cited By (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8123698B2 (en) 2002-10-07 2012-02-28 Suros Surgical Systems, Inc. System and method for minimally invasive disease therapy
US7942802B2 (en) 2002-11-06 2011-05-17 Senorx, Inc. Vacuum device and method for treating tissue adjacent a body cavity
WO2005007229A3 (en) * 2003-07-16 2005-02-24 Scimed Life Systems Inc Temporary tissue spacer and pretreatment balloon
WO2005007229A2 (en) * 2003-07-16 2005-01-27 Scimed Life Systems, Inc. Temporary tissue spacer and pretreatment balloon
EP1682213A4 (en) * 2003-10-10 2009-09-02 Xoft Microtube Inc Applicator for radiation treatment of a cavity
EP1682213A2 (en) * 2003-10-10 2006-07-26 Xoft Microtube, Inc. Applicator for radiation treatment of a cavity
EP1568397A1 (en) * 2004-02-25 2005-08-31 Acrostak Corp. Balloon for brachytherapy and application of the balloon
US9795365B2 (en) 2004-05-21 2017-10-24 Devicor Medical Products, Inc. MRI biopsy apparatus incorporating a sleeve and multi-function obturator
US9638770B2 (en) 2004-05-21 2017-05-02 Devicor Medical Products, Inc. MRI biopsy apparatus incorporating an imageable penetrating portion
US9808650B2 (en) 2004-11-05 2017-11-07 Theragenics Corporation Expandable brachytherapy device
US9623260B2 (en) 2004-11-05 2017-04-18 Theragenics Corporation Expandable brachytherapy device
JP2008526408A (en) * 2005-01-12 2008-07-24 アクロシュターク コーポレイション Indwelling treatment apparatus and treatment method for treatment of ablation cavity wall
US10874381B2 (en) 2005-08-05 2020-12-29 Senorx, Inc. Biopsy device with fluid delivery to tissue specimens
US8915864B2 (en) 2005-08-05 2014-12-23 Senorx, Inc. Biopsy device with fluid delivery to tissue specimens
US10064609B2 (en) 2005-08-05 2018-09-04 Senorx, Inc. Method of collecting one or more tissue specimens
US7981051B2 (en) 2005-08-05 2011-07-19 Senorx, Inc. Biopsy device with fluid delivery to tissue specimens
US8172770B2 (en) 2005-09-28 2012-05-08 Suros Surgical Systems, Inc. System and method for minimally invasive disease therapy
US7407476B2 (en) 2005-11-18 2008-08-05 Senorx, Inc. Tissue irradiation with shielding
US7465268B2 (en) 2005-11-18 2008-12-16 Senorx, Inc. Methods for asymmetrical irradiation of a body cavity
US10413750B2 (en) 2005-11-18 2019-09-17 Hologic, Inc. Brachytherapy device for facilitating asymmetrical irradiation of a body cavity
EP2486957A3 (en) * 2005-11-18 2013-07-10 Senorx, Inc. Tissue irradiation with shielding
US8636637B2 (en) 2005-11-18 2014-01-28 Hologic, Inc Methods for asymmetrical irradiation of a body cavity
WO2007061655A3 (en) * 2005-11-18 2007-11-15 Senorx Inc Tissue irradiation with shielding
US9415239B2 (en) 2005-11-18 2016-08-16 Hologic, Inc. Brachytherapy device for facilitating asymmetrical irradiation of a body cavity
US7517310B2 (en) 2005-11-18 2009-04-14 Senorx, Inc. Methods for tissue irradiation with shielding
US9180312B2 (en) 2005-11-18 2015-11-10 Hologic, Inc. Brachytherapy device for asymmetrical irradiation of a body cavity
WO2007097956A3 (en) * 2006-02-17 2007-10-11 Senorx Inc Temporary catheter for biopsy site tissue fixation
WO2007097956A2 (en) * 2006-02-17 2007-08-30 Senorx, Inc. Temporary catheter for biopsy site tissue fixation
CN101045175B (en) * 2006-03-29 2012-07-04 微创医疗器械(上海)有限公司 Double-layered balloon catheter
WO2008008089A3 (en) * 2006-07-11 2008-03-06 Senorx Inc Asymmetrical irradiation of a body cavity
EP2380630A1 (en) * 2006-10-08 2011-10-26 Cianna Medical, Inc. Expandable brachytherapy apparatus
WO2008045812A1 (en) * 2006-10-08 2008-04-17 Cianna Medical, Inc. Expandable brachytherapy apparatus
US8758214B2 (en) 2007-03-12 2014-06-24 Hologic, Inc. Radiation catheter with multilayered balloon
US8740873B2 (en) 2007-03-15 2014-06-03 Hologic, Inc. Soft body catheter with low friction lumen
US10207126B2 (en) 2009-05-11 2019-02-19 Cytyc Corporation Lumen visualization and identification system for multi-lumen balloon catheter
US10022557B2 (en) 2010-09-30 2018-07-17 Hologic, Inc. Using a guided member to facilitate brachytherapy device swap
US10342992B2 (en) 2011-01-06 2019-07-09 Hologic, Inc. Orienting a brachytherapy applicator
US10201688B2 (en) 2011-03-10 2019-02-12 Western New England University Biopsy spacer device and method of operation
US9233231B2 (en) 2011-03-10 2016-01-12 Western New England University Biopsy spacer device and method of operation
US10835724B2 (en) 2011-03-10 2020-11-17 Western New England University Biopsy spacer device and method of operation
US8932251B2 (en) 2011-03-10 2015-01-13 Western New England University Biopsy spacer device and method of operation
CN104436421A (en) * 2014-11-28 2015-03-25 刘宗军 Medicine injectable balloon

Also Published As

Publication number Publication date
US6955641B2 (en) 2005-10-18
AU2003283014A1 (en) 2004-06-03
US20050240074A1 (en) 2005-10-27
WO2004043531A3 (en) 2004-08-12
EP1558324B1 (en) 2011-06-08
AU2003283014A8 (en) 2004-06-03
US20110172485A1 (en) 2011-07-14
ES2365331T3 (en) 2011-09-29
US20050182286A1 (en) 2005-08-18
US6923754B2 (en) 2005-08-02
US8517906B2 (en) 2013-08-27
CA2504965C (en) 2012-07-03
US8398535B2 (en) 2013-03-19
US20110184222A1 (en) 2011-07-28
US20080064915A1 (en) 2008-03-13
PT1558324E (en) 2011-08-26
US20040087827A1 (en) 2004-05-06
JP4563180B2 (en) 2010-10-13
EP2305340B1 (en) 2012-08-22
EP2305340A1 (en) 2011-04-06
DK1558324T3 (en) 2011-09-19
CA2504965A1 (en) 2004-05-27
US7214178B2 (en) 2007-05-08
US7942802B2 (en) 2011-05-17
JP2006505346A (en) 2006-02-16
US20040215048A1 (en) 2004-10-28
US7935044B2 (en) 2011-05-03
EP1558324A2 (en) 2005-08-03
ATE511874T1 (en) 2011-06-15

Similar Documents

Publication Publication Date Title
EP2305340B1 (en) Vacuum device for treating tissus adjacent a body cavity
US7413539B2 (en) Treatment of a body cavity
CA2296430C (en) Double-wall balloon catheter for treatment of proliferative tissue
US7517310B2 (en) Methods for tissue irradiation with shielding
US8251884B2 (en) Methods for asymmetrical irradiation of a body cavity
US8273006B2 (en) Tissue irradiation
US8303477B2 (en) Fluid radiation shield for brachytherapy

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2003774946

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2504965

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2004551571

Country of ref document: JP

WWP Wipo information: published in national office

Ref document number: 2003774946

Country of ref document: EP